*Storage: Inert atmosphere,2-8°C.
Bendamustine HCl is a DNA-damaging agent with IC50 of 50 μM.
Synonyms: SDX-105;Bendamustine (hydrochloride);Cytostasane HCl;SDX105 HCl;Bendamustine hydrochloride
4.5
*For research use only!
Change View
Size | Price | USA Stock *0-1 Day | Global Stock *5-7 Days | In Stock |
1mg | łÇÊ¶Ê | In Stock | In Stock | Login |
5mg | łÇË¶Ê | In Stock | In Stock | Login |
10mg | łÇÿ¶Ê | In Stock | In Stock | Login |
50mg | łËÿ¶Ê | In Stock | In Stock | Login |
100mg | ł§Ê¶Ê | In Stock | In Stock | Login |
250mg | łÿ§¶Ê | In Stock | In Stock | Login |
1g | łÇËî¶Ê | In Stock | In Stock | Login |
5g | łÍÿÇ¶Ê | In Stock | In Stock | Login |
Please Login or Create an Account to: See VIP prices and availability
łÇʶÊ
łÇ˶Ê
łÇÿ¶Ê
łËÿ¶Ê
ł§Ê¶Ê
łÿ§¶Ê
łÇËî¶Ê
łÍÿǶÊ
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 3543-75-7 |
Formula : | C16H22Cl3N3O2 |
M.W : | 394.72 |
Synonyms : |
SDX-105;Bendamustine (hydrochloride);Cytostasane HCl;SDX105 HCl;Bendamustine hydrochloride
|
MDL No. : | MFCD01658758 |
InChI Key : | ZHSKUOZOLHMKEA-UHFFFAOYSA-N |
Pubchem ID : | 77082 |
GHS Pictogram: | ![]() |
Signal Word: | Warning |
Hazard Statements: | H317-H319 |
Precautionary Statements: | P280-P305+P351+P338 |
In Vitro:
Concentration | Treated Time | Description | Reference |
B cell lymphoma cell lines | 0.625-4.994 μM | 48 hours | NL101 significantly inhibited the proliferation of B cell lymphoma cell lines | PMC7847677 |
Primary B cell lymphoma cells | 3.5 μM | NL101 induced cell death in primary B cell lymphoma cells | PMC7847677 | |
μM1S | 1.6–4.8μM | 48 hours | To evaluate the cytotoxicity of EDO-S101 on μM cell lines, the results showed that EDO-S101 exhibited significant cytotoxicity in all cell lines with IC50 values between 1.6 and 4.8 μM. | PMC5477689 |
μM1R | 20μM | 48 hours | To evaluate the cytotoxicity of Bendamustine on μM cell lines, the results showed that Bendamustine had an IC50 value of 20 μM in the μM1R cell line, significantly higher than EDO-S101. | PMC5477689 |
CLL-B cells | 0.1, 30, 90 μM | 48 hours | Bendamustine in combination with PF-06747143 showed synergistic effects in CLL-B cells, increasing cell death rates. | PMC5438492 |
U87MG | 5.5 - 65.3 μM | To evaluate the inhibitory effect of Bendamustine on cell proliferation | PMC5830080 |
In Vivo:
Administration | Dosage | Frequency | Description | Reference |
NOD-SCID mice | Lymphoma xenograft model | Intravenous injection | 62.5 mg | Once daily for 5 consecutive days | NL101 significantly inhibited the growth of lymphoma xenograft models and prolonged the survival of mice | PMC7847677 |
CB17-SCID mice | subcutaneous plasmacytoma model | intravenous injection | 62.5 mg 5% Imiquimod cream | Every second day for 6 consecutive days | To evaluate the anti-tumor activity of EDO-S101 in the CB17-SCID mouse subcutaneous plasmacytoma model, the results showed that EDO-S101 significantly inhibited tumor growth and prolonged survival. | PMC5477689 |
Mice | JVM-13 CLL xenograft mouse model | Intraperitoneal injection | Low dose group: 10 mg/kg, high dose group: 30 mg/kg | Every other day for 14 days | Bendamustine in combination with PF-06747143 showed synergistic effects in the CLL xenograft model, significantly improving survival rates. | PMC5438492 |
CD1-nu/nu mice | Subcutaneous injection of U251, U87MG, and T98G cells | Intravenous injection | 30 mg/kg | Days 19 and 20, followed by another 2-day treatment cycle 28 days later | To evaluate the antitumor effect of Tinostamustine on tumor growth | PMC5830080 |
NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ mice | MCL xenograft model | Intraperitoneal injection | 40 mg/kg | Once daily for one week | To evaluate the anti-tumor activity of Bendamustine in the MCL xenograft model, results showed that the anti-tumor activity of Bendamustine was comparable in mice transplanted with R clone and CTRL cells | PMC4094598 |
B-NSG mice | MV4-11-luc xenograft model | Intravenous injection | 30 mg/kg | Once daily for 7 days | To evaluate the anti-leukemia effects of NL101 and BMN673 combination therapy in AML xenograft models | PMC6306376 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT02793583 | Diffuse Large B-Cell Lymphoma ... More >> Follicular Lymphoma Marginal Zone Lymphoma Small Lymphocytic Lymphoma Mantle Cell Lymphoma Less << | Phase 2 Phase 3 | Recruiting | July 2019 | - |
NCT01096992 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT02477215 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | May 1, 2020 | United States, Wisconsin ... More >> Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less << |
NCT03609593 | Chronic Lymphocytic Leukemia | Phase 2 | Not yet recruiting | December 31, 2025 | United States, New York ... More >> Columbia University Medical Center Not yet recruiting New York, New York, United States, 10032 Less << |
NCT01317901 | B-cell Small Lymphocytic Lymph... More >>oma Recurrent Less << | Phase 1 | Completed | - | United States, Alabama ... More >> Site Reference ID/Investigator# 61543 Birmingham, Alabama, United States, 35294 United States, Georgia Site Reference ID/Investigator# 61542 Augusta, Georgia, United States, 30912 United States, Nebraska Site Reference ID/Investigator# 61523 Omaha, Nebraska, United States, 68114 United States, New Jersey Site Reference ID/Investigator# 61522 Hackensack, New Jersey, United States, 07601 United States, North Carolina Site Reference ID/Investigator# 61544 Chapel Hill, North Carolina, United States, 27599-7305 United States, Washington Site Reference ID/Investigator# 61524 Seattle, Washington, United States, 98109-1023 Less << |
NCT01686321 | Aggressive Lymphoma | Phase 2 | Unknown | October 2017 | Germany ... More >> Prof. Trümper Recruiting Göttingen, Germany, 37075 Contact: Elke Stitz +49551398546 brenda.studie@med.uni-goettingen.de Contact: Florian Zettl, MD +49551398546 brenda.studie@med.uni-goettingen.de Sub-Investigator: Lorenz Trümper, Prof. Dr. Principal Investigator: Florian Zettl, MD Less << |
NCT01458366 | Non-Hodgkin's Lymphoma | Phase 1 Phase 2 | Active, not recruiting | October 2021 | United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less << |
NCT01701076 | Multiple Myeloma | Phase 2 | Completed | - | Switzerland ... More >> Kantonsspital St. Gallen St. Gallen, Switzerland, 9000 Less << |
NCT02320487 | - | Active, not recruiting | - | - | |
NCT02499627 | Lymphatic Diseases | Phase 2 | Recruiting | October 2021 | Italy ... More >> A.O S.Orsola-Malpighi Recruiting Bologna, BO, Italy, 40138 Principal Investigator: Vittorio Stefoni, MD Spedali Civili Recruiting Brescia, BS, Italy, 25123 Principal Investigator: Giuseppe Rossi, MD Fondazione IRCCS Milano INT Recruiting Milano, MI, Italy, 20133 Principal Investigator: Paolo Corradini, Prof. AO Niguarda Ca' Granda Not yet recruiting Milano, MI, Italy, 20162 Principal Investigator: Chiara Rusconi, MD Istituto Clinico Humanitas Not yet recruiting Rozzano, MI, Italy, 20089 Principal Investigator: Armando Santoro, Prof. AOU Città della Salute e della Scienza Recruiting Torino, TO, Italy, 10126 Principal Investigator: Umberto Vitolo, MD IRCCS Fondazione Pascale Recruiting Napoli, Italy, 80131 Principal Investigator: Antonello Pinto, MD Less << |
NCT02320487 | Chronic Lymphocytic Leukemia | Phase 2 | Active, not recruiting | February 22, 2019 | - |
NCT01078142 | Follicular Lymphoma ... More >> Mantle Cell Lymphoma Less << | Phase 1 Phase 2 | Completed | - | Germany ... More >> Universitätsmedizin Mainz Mainz, Rheinland-Pfalz, Germany, 55131 Less << |
NCT01317901 | - | Completed | - | - | |
NCT01491841 | Non-Hodgkin's Lymphoma | Phase 1 Phase 2 | Active, not recruiting | November 2021 | United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less << |
NCT03623373 | Mantle Cell Lymphoma | Phase 1 | Recruiting | November 30, 2025 | United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Brad S Kahl, M.D. 314-747-6250 bkahl@wustl.edu Principal Investigator: Brad S Kahl, M.D. Sub-Investigator: Nancy Bartlett, M.D. Sub-Investigator: Amanda F Cashen, M.D. Sub-Investigator: Todd Fehniger, M.D., Ph.D. Sub-Investigator: Armin Ghobadi, M.D. Sub-Investigator: Daniel Guy, M.D. Sub-Investigator: Neha Mehta-Shah, M.D. Sub-Investigator: Kathryn Trinkaus, Ph.D. Less << |
NCT02747732 | Diffuse Large B Cell Lymphoma ... More >> Primary Mediastinal (Thymic) Large B-cell Lymphoma Transformed Indolent Lymphoma Recurrent Disease Refractory Cancer Less << | Phase 2 | Recruiting | October 2021 | Israel ... More >> Dr. Meirav Kedmi Not yet recruiting Ramat Gan, Israel, 5262179 Contact: Meirav Kedmi, MD mailto:Meirav.Kedmi@sheba.health.gov.il Contact: Aliza Ackerstein, MASTER Aliza.Ackerstein@sheba.health.gov.il Sheba medical organization Recruiting Ramat Gan, Israel Contact: Meirav Kedmi, MD 972-3-530-2127 Meirav.kedmi@sheba.health.gov.il Contact: Aliza Ackerstein, Msc 972-3-5308402 aliza.ackerstein@sheba.health.gov.il Less << |
NCT01369849 | Chronic Lymphocytic Leukemia ... More >> Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Less << | Phase 1 Phase 2 | Completed | - | - |
NCT01369849 | - | Completed | - | - | |
NCT01029730 | Lymphoma | Phase 2 | Completed | - | - |
NCT02320383 | Chronic Lymphocytic Leucemia | Phase 2 | Active, not recruiting | September 2022 | Germany ... More >> German CLL Study Group Cologne, Germany, 50923 Less << |
NCT01029730 | - | Completed | - | - | |
NCT00790855 | - | Terminated(Lack of Response) | - | - | |
NCT00790855 | Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia Less << | Phase 1 Phase 2 | Terminated(Lack of Response) | - | United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT01168804 | Multiple Myeloma | Phase 2 | Completed | - | Austria ... More >> Medical University Hospital Graz Graz, Austria, 8036 Hospital Elisabethinen Linz Linz, Austria, 4010 LKH Salzburg, 3rd Med. Dept. Salzburg, Austria, 5020 Med. University Vienna, Clinic for Internal Medicine 1 (Hematology and Hemostaseology) Vienna, Austria, 1090 Hanusch Hospital Vienna Vienna, Austria, 1140 Wilhelminenspital Vienna Vienna, Austria, 1160 Clinic Wels-Grieskirchen, 4th Internal Dept. Wels, Austria, 4600 Czech Republic Faculty Hospital Brno Brno, Czech Republic, 63900 Less << |
NCT01871675 | Lymphoma Chro... More >>nic Lymphocytic Leukemia Non-Hodgkin Lymphoma T-cell Lymphoma Less << | Phase 1 | Completed | - | United States, Colorado ... More >> The Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Oklahoma Oklahoma University Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203 Less << |
NCT00992134 | Lymphoma, Mantle-Cell | Phase 2 | Completed | - | Italy ... More >> Department of Hematology, Ospedale San Bortolo Vicenza, VI, Italy, 36100 Less << |
NCT00389051 | Non-Hodgkin's Lymphoma | Phase 1 | Completed | - | Japan ... More >> Kanagawa, Japan Kyoto, Japan Nagoya, Japan Tokyo, Japan Less << |
NCT03424122 | B-cell Lymphoma | Phase 1 | Recruiting | December 13, 2020 | United States, Nevada ... More >> Comprehensive Cancer Centers of Nevada Recruiting Las Vegas, Nevada, United States, 89169 Contact: Study Coordinator 702-952-3400 United States, Texas Texas Oncology-Austin Midtown Recruiting Austin, Texas, United States, 78705 Contact: Study Coordinator 512-421-4100 Texas Oncology-Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States, 75246 Contact: Study Coordinator 214-370-1000 Texas Oncology-San Antonio Northeast Recruiting San Antonio, Texas, United States, 78217 Contact: Study Coordinator 210-656-7177 Texas Oncology San Antonio Medical Center Recruiting San Antonio, Texas, United States, 78240 Contact: Study Coordinator 210-595-5300 Less << |
NCT01754402 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | January 1, 2023 | United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less << |
NCT02623920 | Diffuse Large B Cell Lymphoma ... More >> Mediastinal Large B-cell Lymphoma Grey Zone Lymphoma High Grade B Cell Lymphoma Follicular Lymphoma Marginal Zone Lymphoma Small Lymphocytic Lymphoma Less << | Phase 2 | Withdrawn(Pharmaceutical compa... More >>ny supplying the drug withdraw financial support. PI has decided to close study prior to enrollment of any patients.) Less << | - | United States, Arizona ... More >> Arizona Cancer Center at UMC North Tucson, Arizona, United States, 85724 Less << |
NCT01238146 | Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma Less << | Phase 1 Phase 2 | Withdrawn(No patients accrued.... More >>) Less << | - | United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less << |
NCT00758693 | Chronic Lymphocytic Leukemia | Phase 2 | Withdrawn(Funding was withdraw... More >>n due to insufficient accrual) Less << | - | United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40536 Less << |
NCT02996773 | Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndromes Chronic Myelogenous Leukemia Juvenile Myelomonocytic Leukemia Lymphoma,Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Follicular Marginal Zone Lymphoma Large Cell Lymphoma Mantle-Cell Lymphoma Gray Zone Lymphoma Burkitt Lymphoma Less << | Phase 1 Phase 2 | Recruiting | April 2022 | United States, Arizona ... More >> The University of Arizona Cancer Center Recruiting Tucson, Arizona, United States, 85724 Contact: Olga Ambriz (520) 694-4767 oambriz@email.arizona.edu Principal Investigator: Emmanuel Katsanis, MD Sub-Investigator: Faiz Anwer, MD Sub-Investigator: Daniel Persky, MD Sub-Investigator: Soham Puvvada, MD Sub-Investigator: Ali McBride, PharmD, MS, BCPS Sub-Investigator: Denise J. Roe, DrPH Sub-Investigator: Murali Kodali, MD Sub-Investigator: Lisa Kopp, DO Sub-Investigator: Ravitharan Krishnadasan, MD Sub-Investigator: Sandra Kurtin, NPC Sub-Investigator: Laura McPheeters, NP Sub-Investigator: Jana Montez, NP Sub-Investigator: Lauren Nichols, MD Sub-Investigator: Luz Pelayo-Katsanis, RN, PNP Sub-Investigator: Lauren Sapp, NP Sub-Investigator: Katherine Whitney, NP Sub-Investigator: Andrew Yeager, MD Sub-Investigator: Yi Zeng, MD Less << |
NCT01313611 | Follicular Lymphoma | Phase 2 | Terminated(Treament with ritux... More >>imab during maintenance phase was stoped, according to DSMC recommendations, since 3 cases of deaths occured.) Less << | - | - |
NCT02072967 | - | Completed | - | Russian Federation ... More >> City Clinical Hospital #8 Barnaul, Russian Federation Chelyabinsk Regional Oncology Dispensary/15 Chelyabinsk, Russian Federation, 454087 Vologda Regional Clinical Hospital #2 Cherepovets, Russian Federation Regional Oncology Dispensary/35 Irkutsk, Russian Federation, 664035 Irkutsk Regional Сlinical Hospital/31 Irkutsk, Russian Federation, 664079 Kaluga Regional Clinical Hospital/02 Kaluga, Russian Federation, 248007 District Cancer center od Khanty -Mansiysk Khanty-Mansiysk, Russian Federation City Сlinical Hospital#7/25 Krasnoyarsk, Russian Federation, 660003 Regional Сlinical Hospital/12 Krasnoyarsk, Russian Federation, 660022 Adygei Regional Clinical Oncology Dispensary/11 Maykop, Russian Federation, 385017 Scientific Medical Surgical Center n.a.I.V.Pyrogov/17 Moscow, Russian Federation, 105203 European Medical Center Moscow, Russian Federation, 105229 RONC n.a.N.N.Blokhin/18 Moscow, Russian Federation, 115478 Сentral Clinical Hospital n.a. Semashko N.A./30 Moscow, Russian Federation, 129128 Moscow Scientific Research Oncology Institution n.a.P.A. Gertzen/37 Moscow, Russian Federation, 443099 Central Clinical Hospital of Department of Presidential Affairs Moscow, Russian Federation Municipal Сlinical Hospital № 12/20 Nizhniy Novgorod, Russian Federation, 603003 Novosibirsk State Regional Clinical Hospital/23 Novosibirsk, Russian Federation, 630087 Medical Radiology Scientific Center/38 Obninsk, Russian Federation, 249036 Omsk Regional Clinical Hospital/40 Omsk, Russian Federation, 644111 City Сlinical Hospital#1 n.a.Kabanov A.N./13 Omsk, Russian Federation, 644112 Orenburg State Medical Academy/05 Orenburg, Russian Federation, 460000 Rostov Scientific Research Oncology Institution/01 Rostov-on-Don, Russian Federation, 344037 City Сlinical Oncological Dispensary/22 Saint-Petersburg, Russian Federation, 197022 City Сlinical Hospital#31/08 Saint-Petersburg, Russian Federation, 197110 Military-Medical Academy n.a. Kirova Saint-Petersburg, Russian Federation, 197758 Scientific Research Oncological Institution n.a. Petrov N.N./29 Saint-Petersburg, Russian Federation, 197758 Samara State Medical University' Clinics/36 Samara, Russian Federation, 443099 Road Clinical Hospital on Rostov-Main Station OAO RZhD/06 Smolensk, Russian Federation, 214025 Surgut Regional Clinical Hospital Surgut, Russian Federation Tula Regional Clinical Hospital/21 Tula, Russian Federation, 300053 Volgograd Regional Clinical Oncology Dispensary#1/10 Volgograd, Russian Federation, 400138 Vologda Regional Clinical Hospital/39 Vologda, Russian Federation, 160002 Yekaterinburg Regional Clinical Hospital #1 Yekaterinburg, Russian Federation Sakhalin Regional Oncology Dispensary/32 Yuzhno-Sakhalinsk, Russian Federation, 693010 Less << | |
NCT01165112 | Recurrent Adult Diffuse Large ... More >>Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Less << | Phase 1 Phase 2 | Completed | - | United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less << |
NCT01165112 | - | Completed | - | - | |
NCT03311126 | Mantle Cell Lymphoma ... More >> Non-hodgkin Lymphoma Non Hodgkin Lymphoma Less << | Phase 2 | Recruiting | May 15, 2026 | United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53792 Contact: Cancer Connect 800-622-8922 cancerconnect@uwcarbone.wisc.edu Principal Investigator: Julie Chang, MD Less << |
NCT01754402 | - | Active, not recruiting | - | - | |
NCT01222260 | AL Amyloidosis | Phase 2 | Active, not recruiting | December 2021 | United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Boston Medical Center Boston, Massachusetts, United States, 02118 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10023 Columbia University New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less << |
NCT01929265 | Indolent Non-follicular ... More >> Non-Hodgkin's Lymphoma Less << | Phase 2 | Completed | - | Italy ... More >> SC Ematologia - AO SS. Antonio e Biagio e C. Arrigo Alessandria, AL, Italy, 15121 SC Ematologia Spedali Civili Brescia, BS, Italy Divisione di Ematologia e Trapianti, Ospedale San Maurizio Bolzano, BZ, Italy Divisione di Ematologia, Centro Trapianto di Cellule Staminali San Giovanni Rotondo, Foggia, Italy Divisione Ematologia I , Ospedale San Martino Genova, GE, Italy S.C. Ematologia Azienda Ospedaliera Papardo Messina, ME, Italy Divisione di Oncologia Medica ed Ematologia, Istituto Clinico Humanitas Rozzano, Milano, Italy Divisione di Ematologia Ospedale Niguarda Milano, MI, Italy Centro Oncologico Modenese Modena, MO, Italy Ematologia Azienda Ospedaliero Universitaria Paolo Giaccone Palermo, PA, Italy Div. Oncologia Medica - CRO, Centro di Riferimento Oncologico Aviano, PN, Italy UOC Ematologia 1/CTMO, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano, Italy Oncoematologia Istituto Pascale Napoli, Italy S.C.D.U Ematologia Azienda Ospedaliero Universitaria Maggiore Novara, Italy UO Ematologia Università - Policlinico San Matteo Pavia, Italy Ematologia Ospedale Santo Spirito Pescara, Italy UOA Ematologia, Ospedale Civile Ospedale G. da Saliceto Piacenza, Italy Div. Ematologia AO Bianchi Melacrino Morelli Reggio Calabria, Italy Ematologia, Azienda Ospedaliera Arcispedale "S.Maria Nuova" Reggio Emilia, Italy Ematologia, Università "La Sapienza" Roma, Italy Clinica Ematologia Policlino Le Scotte Siena, Italy Struttura Complessa di Onco-Ematologia Azienda Ospedaliera S.Maria Terni, Italy SC Ematologia - Città della Salute e della Scienza Torino, Italy SC Ematologia U - Città della Salute e della Scienza Torino, Italy Clinica Ematologica e Unità di Terapie Cellulari 'Carlo Melzi' AOU S. Maria della Misericordia Udine, Italy Less << |
NCT00139841 | Non-Hodgkin's Lymphoma | PHASE3 | COMPLETED | 2025-10-09 | University of Alabama Birmingh... More >>am, Birmingham, Alabama, 35233, United States|Arizona Cancer Center, Tucson, Arizona, 85724, United States|Alta Bates Comprehensive Cancer Center, Berkeley, California, 94704, United States|Tower Hematology and Oncology Medical Group, Beverly Hills, California, 90211, United States|Moores UCSD Cancer Center, La Jolla, California, 92093, United States|USC/Norris Cancer Hospital, Los Angeles, California, 90033, United States|Comprehensive Cancer Center - Desert Regional Medical Center, Palm Springs, California, 92662, United States|Stanford University Division of Oncology, Stanford, California, 94305, United States|University of Colorado Cancer Center, Aurora, Colorado, 80010, United States|Yale University School of Medicine, New Haven, Connecticut, 06520, United States|Georgetown University Medical Center, Washington, District of Columbia, 20007, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Indiana Oncology Hematology Consultants, A Division of AHN, Indianapolis, Indiana, 46202, United States|Markey Cancer Center, University of Kentucky Medical Center, Lexington, Kentucky, 40536, United States|LSU Health Sciences Center, Feist Weiller Cancer Center, Shreveport, Louisiana, 71130, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|University of Michigan Cancer Center, Ann Arbor, Michigan, 48109, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Washington University School of Medicine in St. Louis, St. Louis, Missouri, 63110, United States|Nevada Cancer Institute, Las Vegas, Nevada, 89135, United States|University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, 87131, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Weill Cornell Cancer Care Center, New York, New York, 10021, United States|Interlakes Foundation, Inc., Rochester, New York, 14623, United States|University of Rochester Medical Center, James P. Wilmot Cancer Center, Rochester, New York, 14642, United States|Duke University School of Medicine, Durham, North Carolina, 27710, United States|The Cleveland Clinic Foundation Taussig Cancer Center, Cleveland, Ohio, 44195, United States|The West Clinic/ACORN, Memphis, Tennessee, 38138, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Arlington Cancer Center, Arlington, Texas, 76012, United States|University of Virginia Cancer Center, Charlottesville, Virginia, 22908, United States|University of Wisconsin, Madison, Wisconsin, 53792, United States|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada|Queen Elizabeth Health Sciences Centre, Halifax, Nova Scotia, B3H 1V7, Canada|Ottawa Hospital - General Campus, Ottawa, Ontario, KIH8L6, Canada|Hopital Notre-Dame du CHUM, Montreal, Quebec, H2: 4M1, Canada|Hopital du Sacre Couer de Montreal, Montreal, Quebec, H4J 1C5, Canada|Saskatchewan Cancer Center Agency, Saskatoon, Saskatchewan, S7N 4H4, Canada|Hospital Espanol Auxilio Mutuo, Auxilio Mutuo Cancer Center, San Juan, 00919, Puerto Rico Less << |
NCT01570049 | Non-Hodgkin Lymphoma by Clinic... More >>al Course Less << | Phase 3 | Unknown | December 2012 | China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Huaqing Wang, Master +86-022-2334-0123 Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Huaqing Wang, Master Contact: Jian J Yu, Master +8615336402751 yujj@lanjin.cn Less << |
NCT01990144 | Diffuse Large B-cell Lymphoma | Phase 2 | Unknown | February 2016 | - |
NCT00920855 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United States, California ... More >> Pacific Oncololgy & Hematology Encinitas, California, United States Capitol Hematology Oncology Roseville, California, United States University Of California, San Diego San Diego, California, United States James R. Berenson, M.D., Inc. West Hollywood, California, United States United States, District of Columbia George Washington University Washington, District of Columbia, United States United States, Illinois Northshore University Health System Evanston, Illinois, United States United States, Maryland Alivin & Lois Lapidus Cancer Institute Baltimore, Maryland, United States Center for Cancer and Blood Disorders Bethesda, Maryland, United States United States, Massachusetts Sophia Gordon Cancer Center at Lahey Clinic Burlington, Massachusetts, United States United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States United States, South Carolina Charleston Hematology Oncology, PA Charleston, South Carolina, United States United States, Tennessee Family Cancer Center, PLLC Collierville, Tennessee, United States United States, Virginia Fairfax Northern Virginia Hematology Oncology Fairfax, Virginia, United States Less << |
NCT00951457 | Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << | Phase 1 Phase 2 | Completed | - | Austria ... More >> Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie Innsbruck, Tirol, Austria, A-6020 Landeskrankenhaus Feldkirch Feldkirch, Austria, A-6806 A.ö. Landeskrankenhaus Leoben Leoben, Austria, A-8700 Krankenhaus der Elisabethinen Linz Linz, Austria, A-4010 Krankenhaus der Stadt Linz Linz, Austria, A-4020 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 Klinikum Wels-Grieskirchen GmbH Wels, Austria, A-4600 Less << |
NCT00834678 | Breast Cancer | Phase 1 Phase 2 | Completed | - | United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less << |
NCT00834678 | - | Completed | - | - | |
NCT00984542 | Lung Cancer | Phase 2 | Completed | - | United States, Kentucky ... More >> Hardin Memorial Hosptial Elizabethtown, Kentucky, United States, 42701 United States, Tennessee The Jones Clinic - Germantown Germantown, Tennessee, United States, 38138 Jackson-Madison County Hospital Jackson, Tennessee, United States, 38301 Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States, 37901 Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less << |
NCT01657331 | Hodgkin Lymphoma ... More >> Anaplastic Large Cell Lymphoma Less << | Phase 1 Phase 2 | Active, not recruiting | April 2019 | United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10019 Canada, British Columbia British Columbia Cancer Agency Vancouver, British Columbia, Canada, V5z 4E6 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada Less << |
NCT01108341 | Non-Hodgkin's Lymphoma (NHL) | Phase 2 | Completed | - | - |
NCT00920855 | - | Completed | - | - | |
NCT01141725 | Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Myelodysplastic Syndrome With Isolated Del(5q) Untreated Adult Acute Myeloid Leukemia Less << | Phase 1 Phase 2 | Completed | - | United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less << |
NCT01141725 | - | Completed | - | - | |
NCT01049945 | Refractory Multiple Myeloma | Phase 1 Phase 2 | Unknown | - | United States, California ... More >> City of Hope Duarte, California, United States, 91010 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 55904 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637-1470 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington Universtiy School of Medicine St. Louis, Missouri, United States, 63110 Less << |
NCT01108341 | - | Completed | - | - | |
NCT02187133 | Lymphoma, Non-Hodgkin ... More >> Lymphoma Less << | Phase 1 | Recruiting | June 2019 | United States, California ... More >> University of California, Davis Recruiting Davis, California, United States, 95616 Contact: Teri Nguyen crcnguyen@ucdavis.edu Principal Investigator: Joseph Tuscan, MD University of California, San Diego Recruiting San Diego, California, United States, 92093 Contact: Jesika Reiner jreiner@ucsd.edu Principal Investigator: Matthew Wieduwilt, MD University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Erika Cavallone 877-827-3222 cancertrials@ucsf.edu Less << |
NCT01002703 | Multiple Myeloma | Phase 1 Phase 2 | Unknown | October 2014 | Germany ... More >> University of Leipzig Recruiting Leipzig, Germany, 04103 Contact: Dietger Niederwieser +4934197 ext 13050 dietger@medizin.uni-leipzig.de Sub-Investigator: Wolfram Pönisch Less << |
NCT01049945 | - | Unknown | - | - | |
NCT00984542 | - | Completed | - | - | |
NCT01657955 | Chronic Lymphocytic Leukemia ... More >> Leukemia Neoplasms Less << | Phase 3 | Unknown | December 2013 | China ... More >> Hematologic hospital of Chinese academy of medical sciences Recruiting Tianjin, China Contact: Lu G Qiu, M.D. Contact: Jian J Yu, Master +8615336402752 yujj@lanjin.cn Principal Investigator: Lu G Qiu, M.D. Less << |
NCT01900509 | Hodgkin Lymphoma ... More >> Non-Hodgkin Lymphoma Acute Leukemia Less << | Phase 1 | Completed | - | United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less << |
NCT01234467 | Diffuse Large B-Cell Lymphoma ... More >> Lymphoma, Diffuse Large-Cell Diffuse Large-Cell Lymphoma Lymphoma Less << | Phase 2 | Completed | - | United States, North Carolina ... More >> Seby B. Jones Cancer Center Boone, North Carolina, United States, 28607 University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Northeast Medical Center Concord, North Carolina, United States, 28025 Moses Cone Regional Cancer Center Greensboro, North Carolina, United States, 27403 Leo Jenkins Cancer Center, East Carolina University Medical Center Greenville, North Carolina, United States, 27834 Rex Healthcare Raleigh, North Carolina, United States, 27607 Marion L. Shepard Cancer Center Washington, North Carolina, United States, 27889 Less << |
NCT00076349 | Non-Hodgkin's Lymphoma | Phase 2 | Completed | - | - |
NCT01234467 | - | Completed | - | - | |
NCT02110394 | - | Completed | - | Russian Federation ... More >> Republic Clinical Hospital n.a. N.A. Semashko Buryatia, Ulan-Ude, Russian Federation Alexandro-Mariinskaia Regional Clinical Hospital/13 Astrakhan', Russian Federation, 414056 Vologda Reginal Clinical Hospital #2 Cherepovets, Russian Federation Irkutsk Regional Clinical Hospital/08 Irkutsk, Russian Federation, 664079 Kaliningrad City Clinical Hospital Kaliningrad, Russian Federation Regional Clinical Hospital#1/04 Khabarovsk, Russian Federation, 630009 District Cancer Center od Khanty -Mansiysk Khanty-Mansiysk, Russian Federation National Medical Surgical Center n.a.N.I.Pirogov/15 Moscow, Russian Federation, 105203 RONC n.a.N.N.Blokhin/21 Moscow, Russian Federation, 115478 Сentral Clinical Hospital n.a.N.A.Semashko/20 Moscow, Russian Federation, 129128 Central Clinical Hospital of Department of Presidential Affairs Moscow, Russian Federation Haematology Centre at Main Military Clinical Hospital n.a. N.N. Burdenko Moscow, Russian Federation Murmansk Regional Clinical Hospital n.a.P.A.Bayandin/31 Murmansk, Russian Federation, 183047 Nizhniy Novgorod Regional Clinical Hospital n.a.N.A.Semashko/14 Nizhniy Novgorod, Russian Federation, 603126 Medical Radiology Scientific Center/23 Obninsk, Russian Federation, 249036 Omsk Regional Clinical Hospital Omsk, Russian Federation Orenburg State Medical Academy/011 Orenburg, Russian Federation, 460000 Perm regional hospital Perm, Russian Federation Karelia Republican Сlinical Hospital n.a.V.A.Baranov/32 Petrozavodsk, Russian Federation, 185019 Pskov Regional Clinical Hospital Pskov, Russian Federation Rostov Scientific Research Oncology Institution/03 Rostov-on-Don, Russian Federation, 344037 Site 70001 Private Practice Saint-Petersburg, Russian Federation, 197341 Military-Medical Academy n.a. Kirova Saint-Petersburg, Russian Federation, 197758 Samara State Medical University' Clinics/28 Samara, Russian Federation, 443099 Saratov State Medical University n.a. V.I.Razumovskiy Saratov, Russian Federation Road Clinical Hospital on Smolensk station OAO RZhD/12 Smolensk, Russian Federation, 214025 Komi Republican Oncology Dispensary /01 Syktyvkar, Russian Federation, 167904 Tula Regional Clinical Hospital/07 Tula, Russian Federation, 300053 Tyumen Regional Clinical Hospital#1/27 Tyumen, Russian Federation, 625023 Regional Clinical Hospital/26 Ul'yanovsk, Russian Federation, 432063 Volgograd Regional Clinical Oncology Dispensary#1/25 Volgograd, Russian Federation, 400138 Vologda Regional Clinical Hospital Vologda, Russian Federation Yekaterinburg City Hospital #7 Yekaterinburg, Russian Federation Yekaterinburg Regional Clinical Hospital #1 Yekaterinburg, Russian Federation Less << | |
NCT01073163 | - | Completed | - | - | |
NCT00426855 | - | Completed | - | - | |
NCT03336333 | Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << | Phase 3 | Recruiting | October 2022 | - |
NCT02753062 | Diffuse Large B Cell Lymphoma | Phase 2 | Recruiting | August 2023 | Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Songpa-gu, Korea, Republic of, 05505 Contact: Dok Hyun Yoon, M.D.,Ph D 82-10-3235-3090 dhyoon@amc.seoul.kr Contact: Cheolwon Suh, M.D.,Ph D 82-10-3735-3209 csuh@amc.seoul.kr Less << |
NCT00831597 | Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | - | - |
NCT01429025 | Refractory/Relapsed Indolent N... More >>on-Hodgkin Lymphoma Less << | Phase 1 | Active, not recruiting | - | United States, Iowa ... More >> Medical Oncology and Hematology Associates-West Des Moines Clive, Iowa, United States, 50325 Mercy Cancer Center-West Lakes Clive, Iowa, United States, 50325 Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Iowa Oncology Research Association CCOP Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates-Des Moines Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates Des Moines, Iowa, United States, 50314 Mercy Medical Center - Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 Mercy Medical Center-Sioux City Sioux City, Iowa, United States, 51104 St. Luke's Regional Medical Center Sioux City, Iowa, United States, 51104 Methodist West Hospital West Des Moines, Iowa, United States, 50266-7700 Mercy Medical Center-West Lakes West Des Moines, Iowa, United States, 50266 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Dakota Mid Dakota Clinic Bismarck, North Dakota, United States, 58501 Saint Alexius Medical Center Bismarck, North Dakota, United States, 58501 Sanford Bismarck Medical Center Bismarck, North Dakota, United States, 58501 Less << |
NCT03492775 | Indolent Non-hodgkin Lymphoma | Phase 3 | Recruiting | January 5, 2027 | Germany ... More >> Klinikum der Universität München Recruiting München, Bavaria, Germany, 81377 Less << |
NCT01125787 | Chronic Lymphocytic Leukemia (... More >>CLL) Less << | Phase 2 | Terminated(Low enrollment) | - | United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Less << |
NCT01073163 | Non-Hodgkin's Lymphoma ... More >> Mantle Cell Lymphoma Less << | Phase 3 | Completed | - | - |
NCT02002598 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | November 2018 | United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Siyang Leng, MD 212-317-4805 sl4076@cumc.columbia.edu Principal Investigator: Siyang Leng, MD Less << |
NCT01077518 | Lymphoma, Follicular | Phase 3 | Active, not recruiting | June 1, 2024 | - |
NCT00837928 | Metastatic Cancer ... More >> Unspecified Adult Solid Tumor, Protocol Specific Less << | Phase 1 | Completed | - | United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less << |
NCT01131247 | Chronic Lymphocytic Leukemia (... More >>CLL) Less << | Phase 2 | Withdrawn(PI left institution) | - | United States, Arizona ... More >> Mayo Clinic PHoenix/Scottsdale, Arizona, United States, 85259 Less << |
NCT01520922 | Chronic Lymphocytic Leukemia (... More >>CLL) Leukaemia, Lymphocytic, Chronic Less << | Phase 2 | Completed | - | - |
NCT01296256 | Bendamustine ... More >>Conditioning Therapy Autologous Stem Cell Transplant Aggressive Non Hodgkin's Lymphoma Less << | Phase 2 | Completed | - | Spain ... More >> Complejo Hospitalario Universitario de Santiago Santiago, A Coruña, Spain, 15706 Hospital Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11407 Hospital Son Llátzer Palma de Mallorca, Mallorca, Spain, 07198 Hospital Universitario Virgen de Arrixaca El Palmar, Murcia, Spain, 30120 Clinica Universitaria de Navarra Pamplona, Navarra, Spain Hospital Universitario de Canarias Santa Cruz de Tenerife, Tenerife, Spain Hospital Vall d´Hebron Barcelona, Spain, 08035 Hospital Clinic i Provincial Barcelona, Spain, 08036 H. de la Santa Creu i Sant Pau Barcelona, Spain H.U. 12 de Octubre, Madrid, Spain H.U. Gregorio Marañón, Madrid, Spain H.U. La Paz Madrid, Spain H.U. La Princesa Madrid, Spain Hospital Ramon y Cajal Madrid, Spain H. Clínico Universitario de Salamanca Salamanca, Spain H. U. Marqués de Valdecilla. Santander, Spain Hospital Clinico de Valencia Valencia, Spain, 46010 Hospital Arnau de Vilanova Valencia, Spain, 46015 H. La Fe Valencia, Spain Hospital Clínico Lozano Blesa Zaragoza, Spain, 50009 Less << |
NCT02237261 | Multiple Myeloma | Phase 2 | Active, not recruiting | October 2018 | Germany ... More >> Mannheimer Onkologie Praxis Mannheim, Ba-Wü, Germany, 68161 Hämatologisch-Onkologische gemeinschaftspraxis Augsburg, Bayern, Germany, 86150 Gemeinschaftspraxis Dr. R. Schlag/Dr. B. Schöttker Würzburg, Bayern, Germany, 97080 Onkologische Schwerpunktpraxis Heidelberg, BW, Germany, 69115 Medizinische Klinik V, Universitätsklinikum Heidelberg, Sektion Multiples Myelom Heidelberg, BW, Germany, 69120 Onkologische Schwerpunktpraxis Dr. G. Kojouharoff Darmstadt, Hessen, Germany, 64295 Hämatologisch-Onkologische Gemeinschaftspraxis am Bethanienkrankenhaus Frankfurt, Hessen, Germany, 60389 Agaplesion Markus Krankenhaus gGmbH, Medizinisches Versorgungszentrum Frankfurt, Hessen, Germany, 60431 Onkologisches Ambulanzzentrum Hannover am Diakoniekrankenhaus Henriettenstift gGmbH Hannover, NRW, Germany, 30171 Onkologische Gemeinschaftspraxis Köln, NRW, Germany, 50677 Klinikum Idar-Oberstein GmbH, Innere Medizin I Idar-Oberstein, Rh-Pfalz, Germany, 55743 Onkologische Schwerpunktpraxis Speyer Speyer, RP, Germany, 67346 Städtische Klinikum Dessau Dessau, Sachsen-Anhalt, Germany, 06847 Klinikum Aschaffenburg, Med. Klinik II Aschaffenburg, Germany, 63739 Onkologische Praxis Oldenburg/Delmenhorst Oldenburg, Germany, 26121 Less << |
NCT01520922 | - | Completed | - | - | |
NCT01010568 | - | Terminated(Unable to accrue pa... More >>tients due to change in standard CLL therapy) Less << | - | - | |
NCT01326702 | Adult B Acute Lymphoblastic Le... More >>ukemia Adult Nasal Type Extranodal NK/T-Cell Lymphoma Adult Solid Neoplasm Anaplastic Large Cell Lymphoma Angioimmunoblastic T-Cell Lymphoma Chronic Lymphocytic Leukemia Cutaneous B-Cell Non-Hodgkin Lymphoma Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Hepatosplenic T-Cell Lymphoma Intraocular Lymphoma Lymphomatous Involvement of Non-Cutaneous Extranodal Site Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Nodal Marginal Zone Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-Cell Leukemia/Lymphoma Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides and Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Plasma Cell Myeloma Small Intestinal Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenstrom Macroglobulinemia Less << | Phase 1 Phase 2 | Completed | - | United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less << |
NCT01352312 | Chronic Lymphocytic Leukemia ... More >> B-Cell Non-Hodgkin's Lymphoma Less << | Phase 1 | Terminated(Insufficient accrua... More >>l over 12 mo period) Less << | - | United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less << |
NCT00426855 | Lymphoma, Non-Hodgkin | Phase 1 Phase 2 | Completed | - | - |
NCT00661739 | Metastatic Breast Cancer | Phase 1 | Completed | - | - |
NCT02433795 | Marginal Zone B-cell Lymphoma | Phase 2 | Active, not recruiting | December 2018 | Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of, 54907 Hallym University Medical Center Anyang-si, Korea, Republic of Chungnam National University Daejeon, Korea, Republic of Gachon University Gil Medical Center Incheon, Korea, Republic of Gyeongsang National University Hospital Jinju, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Inje Universit Seoul, Korea, Republic of Korea Cancer Center Hospital Seoul, Korea, Republic of Seoul National University Boramae Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of The Catholic University of Korea Seoul, Korea, Republic of Less << |
NCT01022021 | Lymphoma | Early Phase 1 | Completed | - | United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66205 Less << |
NCT01010568 | Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << | Phase 2 | Terminated(Unable to accrue pa... More >>tients due to change in standard CLL therapy) Less << | - | United States, District of Col... More >>umbia Georgetown University Washington, District of Columbia, United States, 20007 Less << |
NCT00705250 | Hodgkin's Disease ... More >> Lymphoma Less << | Phase 2 | Completed | - | United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
NCT00705250 | - | Completed | - | - | |
NCT01315873 | Multiple Myeloma | Phase 2 | Terminated(PI left the institu... More >>tion before all data analysis was completed) Less << | - | United States, New York ... More >> New York University Langone Medical Center New York, New York, United States, 10016 Less << |
NCT01649622 | Leukemia Lymp... More >>homa Less << | Phase 2 | Withdrawn | - | - |
NCT01500083 | Indolent Non-Hodgkin's Lymphom... More >>a Chronic Lymphocytic Leukemia Less << | Phase 3 | Completed | - | Canada, Alberta ... More >> CA015 Calgary, Alberta, Canada, T2N 4N2 CA014 Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia CA016 Kelowna, British Columbia, Canada, V1Y 5L3 CA011 Vancouver, British Columbia, Canada, V5Z 4E6 CA013 Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CA012 Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia CA004 Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario CA009 Brampton, Ontario, Canada, L6R 3J7 CA003 Hamilton, Ontario, Canada, L8V 5C2 CA002 Ottawa, Ontario, Canada, K1H 8L6 CA006 Toronto, Ontario, Canada, M5G 2M9 CA005 Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec CA001 Montreal, Quebec, Canada, H2W 1S6 CA010 Montreal, Quebec, Canada, H4J 1C5 Canada, Saskatchewan CA007 Saskatoon, Saskatchewan, Canada, S7N 4H4 Canada CA008 Quebec, Canada, G1J 1Z4 Less << |
NCT01152203 | Advanced Cancer | Phase 1 | Completed | - | United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT01891227 | Breast Cancer | Phase 2 | Completed | - | Austria ... More >> Hämatologie und Onkologie/Interne E, LKH Feldkirch Feldkirch, Austria, A-6807 Universitätsklinik f. Frauenheilkunde und Geburtshilfe, Klin. Abt. f. Gynäkologie Graz, Austria, 8036 Universitätsklinik f. Innere Medizin, Klin.Abt. f. Onkologie Graz, Austria, 8036 Univ.-Klinik f. Frauenheilkunde; Klinische Abt. f. Gynäkologie u. Geburtshilfe Innsbruck, Austria, A-6020 KH Barmh. Schwestern Linz, Innere Medizin I Hämatologie/Onkologie Linz, Austria, A-4010 Kepler Universitätsklinikum, Med Campus III, Klinik f. Interne 3 - Schwerpunkt Hämatologie u. Onkologie Linz, Austria, A-4021 Universitätsklinik für Innere Medizin III Salzburg, Austria, A-5020 Landeskrankenhaus Steyr, Interne Medizin II Steyr, Austria, A-4400 Less << |
NCT00891839 | Mantle Cell Lymphoma | Phase 2 | Completed | - | United States, California ... More >> Teva Investigational Site 11 Fountain Valley, California, United States Teva Investigational Site 2 Los Angeles, California, United States United States, Florida Teva Investigational Site 35 Orlando, Florida, United States United States, Indiana Teva Investigational Site 30 Lafayette, Indiana, United States United States, Maryland Teva Investigational Site 20 Bethesda, Maryland, United States United States, New Jersey Teva Investigational Site 4 Hackensack, New Jersey, United States United States, New York Teva Investigational Site 3 Buffalo, New York, United States United States, Pennsylvania Teva Investigational Site 43 Gettysburg, Pennsylvania, United States United States, Texas Teva Investigational Site 33 Bryan, Texas, United States Teva Investigational Site 41 Grapevine, Texas, United States United States, Virginia Teva Investigational Site 23 Lynchburg, Virginia, United States Canada Teva Investigational Site 6 Ottawa, Canada Teva Investigational Site 7 Toronto, Canada Less << |
NCT01315873 | - | Terminated(PI left the institu... More >>tion before all data analysis was completed) Less << | - | - | |
NCT01109264 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | China ... More >> Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine Shanghai, China Less << |
NCT01739491 | - | Withdrawn(The study is cancell... More >>ed. FDA Circular 2013-004 mandates that PMSs like this are not required) Less << | November 2016 | - | |
NCT01500083 | - | Completed | - | - | |
NCT02095834 | Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << | Phase 1 | Active, not recruiting | April 30, 2021 | United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT00891839 | - | Completed | - | - | |
NCT02224729 | Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << | Phase 2 | Active, not recruiting | January 2020 | United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less << |
NCT01626352 | Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | - | United States, Florida ... More >> Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists North Saint Petersburg, Florida, United States, 33705 Space Coast Cancer Center Titusville, Florida, United States, 32796 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 RHHP/Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Michigan Grand Rapids Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Oklahoma Cancer Centers of Southwest Oklahoma Lawton, Oklahoma, United States, 73505 Oklahoma University Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Tennessee Oncology-Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less << |
NCT02224729 | - | Active, not recruiting | - | - | |
NCT00879073 | Brain Metastases | Phase 1 | Terminated(Principal Investiga... More >>tor is leaving Moffitt) Less << | - | United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less << |
NCT01626352 | - | Completed | - | - | |
NCT00823797 | Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Neoplasm Less << | Phase 2 | Completed | - | United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less << |
NCT00863850 | Malignancy | Phase 1 | Completed | - | Netherlands ... More >> Please Call For Information Amsterdam, Netherlands, 1066 CX Less << |
NCT00823797 | - | Completed | - | - | |
NCT00947388 | Recurrent Small Lymphocytic Ly... More >>mphoma Refractory Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma Less << | Phase 1 | Terminated(No more eligible pa... More >>tients) Less << | - | United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less << |
NCT01088984 | Leukemia | Phase 1 Phase 2 | Completed | - | - |
NCT02240719 | Recurrent Adult Diffuse Large ... More >>Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Refractory Chronic Lymphocytic Leukemia Multiple Myeloma Less << | Phase 1 | Active, not recruiting | December 2019 | United States, California ... More >> University of California Davis Sacramento, California, United States, 95817 Less << |
NCT01484626 | - | Terminated(Celgene would no lo... More >>nger supply lenalidomide for the study) Less << | - | - | |
NCT01484626 | Multiple Myeloma | Phase 1 Phase 2 | Terminated(Celgene would no lo... More >>nger supply lenalidomide for the study) Less << | - | United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less << |
NCT01088984 | - | Completed | - | - | |
NCT00959686 | T-cell Lymphoma | Phase 2 | Completed | - | France ... More >> Dr Gandhi DAMAJ Amiens, France, 80054 Less << |
NCT03343652 | Hodgkin's Lymphoma | Phase 1 Phase 2 | Recruiting | March 27, 2020 | Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Natalya B Mikhailova, PhD +7-921-909-62-09 bmt.lymphoma@gmail.com Contact: Elena V Kondakova, PhD +79650094653 kondakovae@mail.ru Sub-Investigator: Kirill V Lepik, MD Less << |
NCT02168907 | B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Chronic Lymphocytic Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << | Phase 1 | Terminated(Slow Accruals) | - | United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less << |
NCT02168140 | Adult Lymphocyte Depletion Hod... More >>gkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Hepatosplenic T-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Hodgkin Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome T-cell Adult Acute Lymphoblastic Leukemia T-cell Large Granular Lymphocyte Leukemia Less << | Phase 1 | Recruiting | July 2020 | United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Zanetta S. Lamar 336-716-7448 zlamar@wakehealth.edu Principal Investigator: Zanetta S. Lamar United States, Pennsylvania Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Joseph Vena, RN mailto:Joseph.Vena@uphs.upenn.edu Contact: Tanya Latorre mailto:Tanya.Latorre@uphs.upenn.edu Less << |
NCT02315157 | Multiple Myeloma ... More >> Plasma Cell Leukemia Less << | Phase 1 | Withdrawn(Withdrawn by PI) | - | United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less << |
NCT01535924 | Adult Lymphocyte Depletion Hod... More >>gkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Recurrent Adult Hodgkin Lymphoma Less << | Phase 1 Phase 2 | Active, not recruiting | December 31, 2018 | United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less << |
NCT00867503 | - | Completed | - | - | |
NCT00867503 | Ovarian Cancer | Phase 2 | Completed | - | United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 Less << |
NCT01596621 | Non-Hodgkin Lymphoma | PHASE3 | COMPLETED | 2017-04-24 | Teva Investigational Site 001,... More >> Beijing, 100021, China|Teva Investigational Site 026, Beijing, 100029, China|Teva Investigational Site 022, Beijing, 100044, China|Teva Investigational Site 004, Beijing, 100071, China|Teva Investigational Site 003, Beijing, 100142, China|Teva Investigational Site 002, Beijing, 100191, China|Teva Investigational Site 023, Beijing, 100600, China|Teva Investigational Site 016, Beijing, 100730, China|Teva Investigational Site 021, Beijing, 110108, China|Teva Investigational Site 015, Changchun, 130000, China|Teva Investigational Site 010, Chengdu, 610041, China|Teva Investigational Site 008, Guangzhou, 510000, China|Teva Investigational Site 007, Guangzhou, 510060, China|Teva Investigational Site 011, Hangzhou, 310003, China|Teva Investigational Site 019, Harbin, 150081, China|Teva Investigational Site 025, Hefei, 230022, China|Teva Investigational Site 024, Lanzhou, 620102, China|Teva Investigational Site 012, Nanjing, 210000, China|Teva Investigational Site 013, Nanjing, 210029, China|Teva Investigational Site 006, Shanghai, 200032, China|Teva Investigational Site 005, Shanghai, 200035, China|Teva Investigational Site 009, Shenyang, 110001, China|Teva Investigational Site 027, Shenyang, 110042, China|Teva Investigational Site 020, Suzhou, 215000, China|Teva Investigational Site 014, Tianjin, 300041, China|Teva Investigational Site 018, Xi'an, 710032, China|Teva Investigational Site 017, Zhengzhou, 450000, China Less << |
NCT00899431 | Chronic Lymphocytic Leukemia | Phase 2 | Active, not recruiting | May 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT03570892 | Non-Hodgkin Lymphoma | Phase 3 | Not yet recruiting | May 26, 2025 | - |
NCT01587040 | Neoplasm Malignant | Phase 1 Phase 2 | Completed | - | - |
NCT00889798 | - | Active, not recruiting | December 2019 | - | |
NCT02788201 | Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << | Phase 2 | Recruiting | July 1, 2020 | United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Less << |
NCT01178086 | - | Completed | - | Germany ... More >> PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann Frechen, Germany, 50226 Less << | |
NCT01438177 | Multiple Myeloma | Phase 2 | Terminated(PI left institution... More >>.) Less << | - | United States, New York ... More >> NYU Cancer Institute New York, New York, United States, 10016 Less << |
NCT01178086 | - | Completed | - | - | |
NCT02877550 | Follicular Lymphoma | Phase 1 | Recruiting | December 2021 | Switzerland ... More >> Universitaetsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Fatime Krasniqi, MD +41 61 265 5059 KrasniqiF@uhbs.ch Principal Investigator: Fatime Krasniqi, MD Istituto Oncologico della Svizzera Italiana Recruiting Bellinzona, Switzerland, 6500 Contact: Anastasios Stathis, MD +41 91 811 89 31 anastasios.stathis@eoc.ch Principal Investigator: Anastasios Stathis, MD Inselspital, Bern Recruiting Bern, Switzerland, CH-3010 Contact: Urban Novak, MD +41 31 632 19 92 urban.novak@insel.ch Principal Investigator: Urban Novak, MD Kantonsspital Graubünden Recruiting Chur, Switzerland, 7000 Contact: Ulrich Mey, MD +41 81 256 68 85 ulrich.mey@ksgr.ch Principal Investigator: Ulrich Mey, MD Hopital Cantonal Universitaire de Geneve Recruiting Geneva, Switzerland, CH-1211 Contact: Nicolas Mach, MD 41-22-372-9881 Nicolas.Mach@hcuge.ch Principal Investigator: Nicolas Mach, MD Kantonsspital - St. Gallen Recruiting St. Gallen, Switzerland, CH-9007 Contact: Felicitas Hitz, MD +41 71 494 11 11 felicitas.hitz@kssg.ch Principal Investigator: Felicitas Hitz, MD Less << |
NCT02689869 | Indolent Non-Hodgkin Lymphoma | Phase 2 | Active, not recruiting | July 2022 | Germany ... More >> Klinikum der Universität München München, Bavaria, Germany, 81377 Less << |
NCT01849848 | Relapsed/Refractory Multiple M... More >>yeloma Less << | Phase 2 | Completed | - | Japan ... More >> Chuo-ku, Japan Fukuoka, Japan Isehara, Japan Koto-ku, Japan Kyoto, Japan Nagoya, Japan Niigata, Japan Okayama, Japan Sapporo, Japan Sendai, Japan Shibukawa, Japan Shibuya-ku, Japan Tokushima, Japan Utsunomiya, Japan Less << |
NCT03671018 | B-cell Non-Hodgkin Lymphoma | Phase 1 | Recruiting | September 28, 2023 | United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 United States, Florida University of Miami Miller School of Medicine Recruiting Miami, Florida, United States, 33136 Less << |
NCT02273856 | - | Terminated(The study was termi... More >>nated due to insufficient subject enrollment and very slow enrollment.) Less << | - | Jordan ... More >> Site JO96201 King Abdullah University Hospital Irbid, Jordan, 22110 Kuwait Site KW96501 Kuwait Cancer Control Center Shuwaikh, Kuwait, 70653 Lebanon Site Hammoud Hospital University Medical Center Beirut, Lebanon, 1600 Site Hotel Dieu De France Beirut, Lebanon, 166830 Oman Site OM96801 Sultan Qaboos University Hospital Muscat, Oman, 123 Qatar Site Hamad Medical Coorporation, National Center for Cancer Care and Research, Al Amal Hospital Doha, Qatar, 3050 Saudi Arabia Site SA96601 Aseer Central Hospital Abha, Aseer, Saudi Arabia, 61421 United Arab Emirates Site AE97101 Sheikh Khalifa Medical City Abu Dhabi, United Arab Emirates, 51900 Less << | |
NCT01849848 | - | Completed | - | - | |
NCT02951156 | Diffuse Large B-Cell Lymphoma | Phase 3 | Active, not recruiting | May 29, 2021 | - |
NCT02950051 | Chronic Lymphocytic Leukemia | Phase 3 | Recruiting | January 2024 | - |
NCT02690545 | Lymphoma Lymp... More >>homa, Non-Hodgkin Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type Less << | Phase 1 Phase 2 | Recruiting | October 2034 | United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng 919-445-4208 catherine_cheng@med.unc.edu Contact: Spencer Laing 919-962-8618 ssblaing@email.unc.edu Principal Investigator: Anne Beaven, MD Less << |
NCT01476787 | Follicular Lymphoma | Phase 3 | Active, not recruiting | June 1, 2024 | - |
NCT01438177 | - | Terminated(PI left institution... More >>.) Less << | - | - | |
NCT01650701 | Follicular Lymphoma | Phase 3 | Active, not recruiting | September 2024 | - |
NCT01488162 | - | Completed | - | - | |
NCT02130869 | Neuroblastoma ... More >> Lymphoma High-risk Tumor Less << | Phase 1 | Completed | - | United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less << |
NCT01332968 | Non-Hodgkin's Lymphoma | Phase 3 | Active, not recruiting | April 8, 2021 | - |
NCT00634881 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Completed | - | Germany ... More >> Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Klinikum Barnim GmbH, Werner Forssmann Krankenhaus Eberswalde, Germany, 16225 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69115 Klinikum Lippe - Lemgo Lemgo, Germany, D-32657 III Medizinische Klinik Mannheim Mannheim, Germany, D-68305 Krankenhaus Barmherzige Brueder Regensburg Regensburg, Germany, D-93049 Less << |
NCT03602157 | Lymphoma Lymp... More >>homa, Non-Hodgkin Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Less << | Phase 1 | Recruiting | May 30, 2036 | United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng 919-445-4208 catherine_cheng@med.unc.edu Contact: Spencer Laing 919-962-8618 spencer.laing@med.unc.edu Less << |
NCT01332968 | - | Active, not recruiting | - | - | |
NCT01724021 | Diffuse Large B-Cell Lymphoma,... More >> Non-Hodgkin's Lymphoma Less << | Phase 3 | Completed | - | - |
NCT02416206 | Multiple Myeloma | Phase 2 | Recruiting | May 2020 | United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Recruiting Atlanta, Georgia, United States, 30342 Contact: Scott R. Solomon, MD 404-255-1930 Less << |
NCT01088048 | Indolent Non-Hodgkin's Lymphom... More >>a Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Less << | Phase 1 | Completed | - | United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, California UCLA Los Angeles, California, United States, 90024 Stanford Cancer Center Palo Alto, California, United States, 94304-5548 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Weill Medical College of Cornell New York, New York, United States, 10021 United States, Oregon Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States, 97477 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 United States, Washington North Star Lodge Cancer Center Yakima, Washington, United States, 98902 Less << |
NCT03187210 | Lymphoma | Phase 1 Phase 2 | Recruiting | June 2022 | Switzerland ... More >> Department for Medical Oncology University Hospital/Inselspital Recruiting Berne, Switzerland, 3010 Principal Investigator: Thomas Pabst, Prof Dr med Less << |
NCT01889069 | Lymphoma | Phase 3 | Active, not recruiting | June 15, 2019 | Italy ... More >> Irccs Crob Rionero in Vulture, Basilicata, Italy, 85028 Azienda Ospedaliera Bianchi-Melacrino-Morelli; Unità Operativa di Ematologia Reggio Calabria, Calabria, Italy, 89100 Azienda Ospedaliera S.G. Moscati; Divisione Ematologia Avellino, Campania, Italy, 83100 Asl ce - p.o. Avers; Uoc ematologia Aversa, Campania, Italy, 81031 A.O. San Sebastiano; U.O.C. Oncologia Caserta, Campania, Italy, 81100 Seconda università degli studi di napoli; Medicina clinica e sperimentale magrassi - lanzara Napoli, Campania, Italy, 80138 Osp. Santa Maria Goretti; Ematologia Latina, Lazio, Italy, 04100 Ospedale S. Eugenio; Divisione Di Ematologia Roma, Lazio, Italy, 00144 Regina Elena National Cancer Institute; Hematology Roma, Lazio, Italy, 00144 Az. Osp. S. Camillo Forlanini; Uo Ematologia E Trapianti Di Midollo Osseo Roma, Lazio, Italy, 00152 Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol Roma, Lazio, Italy, 00161 Azienda Ospedaliera S. Giovanni Addolorata; UOC Ematologia Roma, Lazio, Italy, 00184 ASL Viterbo; Presidio Ospedaliero di Ronciglione; UOC Ematologia Ronciglione, Lazio, Italy, 01037 Ospedale Valduce;U.O.S. Oncologia Ed Ematologia Como, Lombardia, Italy, 22100 ASST DI CREMA; U O Oncologia Medica Crema, Lombardia, Italy, 26013 ASST DI LECCO; Oncologia Medica Lecco, Lombardia, Italy, 23900 Az. Osp. Carlo Poma; Divisione Di Oncologia Medica Mantova, Lombardia, Italy, 46100 Osp. San Raffaele; Dip. Di Oncoematologia Milano, Lombardia, Italy, 20132 Ist. Nazionale Per Lo Studio E Cura Dei Tumori; Div. Ematologia Trapianto Midollo Osseo Allogenico Milano, Lombardia, Italy, 20133 Irccs Policlinico San Matteo; Divisione Di Ematologia Pavia, Lombardia, Italy, 27100 Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia Rozzano, Lombardia, Italy, 20089 Ospedale Gen.Le Prov.Le 'C.G.Mazzoni'; Ematologia Ascoli Piceno, Marche, Italy, 63100 Ospedale di Civitanova Marche; Medicina Interna Civitanova Marche, Marche, Italy, 62012 Ospedale di Macerata; Medicina Generale Macerata, Marche, Italy, 62100 Università Cattolica Del Sacro Cuore S.S. Giovanni Paolo Ii; Uoc Di Onco-Ematologia Campobasso, Molise, Italy, 86100 Ospedale Civile SS. Antonio E Biagio DI Alessandria; Ematologia Alessandria, Piemonte, Italy, 15121 Univ. Piemonte Est Amedeo Avogadro; Div.Ematologia- Dip.Clinica Med.Sperim.& Ircad Novara, Piemonte, Italy, 28100 Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica Bari, Puglia, Italy, 70124 Azienda ospedaliera oo rr di foggi; Hematology Foggia, Puglia, Italy, 71100 Ospedale S.Nicola Pellegrino; Reparto Di Ematologia Trani, Puglia, Italy, 70059 Ospedale Roberto Binaghi; Centro trapianti di midollo osseo Cagliari, Sardegna, Italy, 09126 Osp. San Francesco; Ematologia e CTMO Nuoro, Sardegna, Italy, 08100 ARNAS Garibaldi; Ematologia Catania, Sicilia, Italy, 95122 Az. Osp. Papardo; Struttura Complessa Di Ematologia Messina, Sicilia, Italy, 98165 ARNAS-Ospedale Civico Maurizio Ascoli; Unità Operativa di Oncologia Medica Palermo, Sicilia, Italy, 90127 Azienda Uni Ria Policlinico P. Giaccone ; Divisione Di Ematologia E Trapianto Palermo, Sicilia, Italy, 90127 Ospedale Santa Chiara; Unita Operativa Di Ematologia Pisa, Toscana, Italy, 56100 USL 4 di Prato - Nuovo Ospeale di Prato Prato, Toscana, Italy, 59100 A.O. Santa Maria Terni; S.C. Oncoematologia Terni, Umbria, Italy, 05100 IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II Padova, Veneto, Italy, 35128 Less << |
NCT01905943 | Chronic Lymphocytic Leukemia | Phase 3 | Completed | - | - |
NCT02063685 | Follicular Non-Hodgkin's Lymph... More >>oma Less << | Phase 3 | Active, not recruiting | December 2021 | - |
NCT02134262 | Relapsed or Refractory B-Cell ... More >>Non-Hodgkin Lymphoma Less << | Phase 1 Phase 2 | Unknown | March 2017 | Japan ... More >> Jichi Medical University Recruiting Shimotsuke, Tochigi, Japan, 329-0498 Contact: Ken Ohmine, MD, PhD +81-285-58-7353 omineken@jichi.ac.jp Principal Investigator: Keiya Ozawa, MD, PhD Less << |
NCT01724021 | - | Completed | - | - | |
NCT03593018 | Relapsed Angioimmunoblastic T-... More >>Cell Lymphoma Refractory Angioimmunoblastic T-cell Lymphoma Less << | Phase 3 | Recruiting | December 2021 | Belgium ... More >> A. Z. Sint-Jan Brugge-Oostende AV Recruiting Bruges, Belgium Contact: Sylvia SNAUWAERT, MD Cliniques Universitaires de Bruxelles - Hôpital Erasme Recruiting Bruxelles, Belgium Contact: Alice WOLFROMM, MD Université Catholique de Louvain Saint-Luc Recruiting Bruxelles, Belgium Contact: Nicole STRAETMANS, MD CHU de Liège Recruiting Liège, Belgium Contact: Christophe BONNET, MD CHU UCL Namur - Site Godinne Recruiting Yvoir, Belgium Contact: Marc ANDRE, MD France Institut d'Hématologie de Basse Normandie Recruiting Caen, France Contact: Gandhi DAMAJ, MD CHU de Clermont-Ferrand - Hôpital Estaing Recruiting Clermont-Ferrand, France Contact: Olivier TOURNILHAC, MD CHU Henri Mondor Recruiting Créteil, France Contact: Jehan DUPUIS, MD CHU de Dijon Recruiting Dijon, France Contact: Olivier CASASNOVAS, MD CHU de Grenoble Recruiting Grenoble, France Contact: Rémy GRESSIN, MD CHRU de Lille Recruiting Lille, France Contact: Franck MORSCHHAUSER, MD CHU de Limoges Recruiting Limoges, France Contact: Céline KENNEL, MD CHU de Montpellier - Hôpital Saint-Eloi Recruiting Montpellier, France Contact: Guillaume CARTRON, MD CHU de Nantes - Hôtel Dieu Recruiting Nantes, France Contact: Steven LE GOUILL, MD Hôpital Necker Recruiting Paris, France Contact: Richard DELARUE, MD Hôpital Saint-Louis Recruiting Paris, France Contact: Catherine THIEBLEMONT, MD CHU Haut-Lévèque - Centre François Magendie Recruiting Pessac, France Contact: Kamal BOUABDALLAH, MD CHU Lyon-Sud Recruiting Pierre-Bénite, France Contact: Emmanuel BACHY, MD CH Annecy Genevois Recruiting Pringy, France Contact: Nicolas DAGUINDAU, MD CHU Pontchaillou Recruiting Rennes, France Contact: Roch HOUOT, MD Centre Henri Becquerel Recruiting Rouen, France Contact: Hervé TILLY, MD IUCT - Oncopole Recruiting Toulouse, France Contact: Loïc YSEBAERT, MD CHRU de Nancy - Hôpital de Brabois Recruiting Vandœuvre-lès-Nancy, France Contact: Lauriane CLEMENT-FILLIATRE, MD Less << |
NCT02194374 | Leukemia | Phase 1 | Withdrawn(Study closed with no... More >> enrollment due to unavailability of reagent.) Less << | - | - |
NCT02153580 | Post-transplant Lymphoprolifer... More >>ative Disorder B-Cell Prolymphocytic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Recurrent Lymphoplasmacytic Lymphoma Less << | Phase 1 | Recruiting | December 2021 | United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Tanya Siddiqi 800-826-4673 Principal Investigator: Tanya Siddiqi Less << |
NCT00877214 | Follicular Lymphomas ... More >> Immunocytomas Marginal Zone Lymphomas Mantle-Cell Lymphomas Lymphocytic Lymphoma Non-Hodgkin's Lymphoma Less << | Phase 3 | Active, not recruiting | April 2022 | Germany ... More >> StiL Head Office; Justus-Liebig-University Giessen, Germany, 35392 Less << |
NCT00385125 | Lymphoma, High-Grade | Phase 2 | Unknown | - | Germany ... More >> University of Magdeburg, departement of Hematology and Oncology Recruiting Magdeburg, Germany, 39120 Principal Investigator: Martin Mohren, PD Less << |
NCT03269669 | Grade 1 Follicular Lymphoma ... More >> Grade 2 Follicular Lymphoma Grade 3a Follicular Lymphoma Recurrent Follicular Lymphoma Refractory Follicular Lymphoma Less << | Phase 2 | Recruiting | December 31, 2022 | - |
NCT03755804 | Hodgkin Lymphoma | Phase 2 | Recruiting | July 1, 2028 | United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Jamie Flerlage, MD, MS 866-278-5833 referralinfo@stjude.org Less << |
NCT01905943 | - | Completed | - | - | |
NCT02278796 | Lymphoma, Large B-Cell, Diffus... More >>e Lymphoma, Follicular Lymphoma, Mantle-Cell Less << | Phase 2 | Active, not recruiting | December 2019 | Austria ... More >> Krankenhaus der Elisabethinen Linz Linz, Austria, 4020 Hanusch Krankenhaus Wien Wien, Austria, 1140 Switzerland Department for Medical Oncology University Hospital/Inselspital Berne, Switzerland, 3010 Universitätsspital Zürich Zürich, Switzerland, 8091 Less << |
NCT02626455 | Lymphoma, Non-Hodgkin | Phase 3 | Recruiting | December 31, 2024 | - |
NCT02467946 | Clinical Efficacy ... More >> Safety Less << | Phase 1 Phase 2 | Recruiting | December 2021 | France ... More >> Centre Antoine Lacassagne Recruiting Nice, France, 06000 Contact: Antoine THYSS, Phd +33492031497 antoine.thyss@nice.unicancer.fr Contact: LOVERA Christine +33492031618 christine.lovera@nice.unicancer.fr Principal Investigator: Simonetta VIVIANI, Phd Less << |
NCT01716806 | Hodgkin Disease | Phase 2 | Recruiting | July 2021 | - |
NCT02733042 | Lymphoma Leuk... More >>emia, Lymphocytic, Chronic, B-Cell Less << | Phase 1 Phase 2 | Active, not recruiting | July 8, 2022 | - |
NCT01831505 | Lymphoma | Phase 1 | Completed | - | United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less << |
NCT03696784 | Lymphoma Lymp... More >>homa, B-Cell Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Less << | Phase 1 | Not yet recruiting | October 30, 2033 | United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng 919-445-4208 catherine_cheng@med.unc.edu Contact: Spencer Laing 919-962-8618 ssblaing@email.unc.edu Principal Investigator: Grover Natalie, MD Less << |
NCT01232556 | Lymphoma, Non-Hodgkin | Phase 3 | Terminated(The study was termi... More >>nated prematurely on May 16, 2013, for futility. No new or unexpected safety issues were identified.) Less << | - | - |
NCT01490723 | Leukemia Lymp... More >>homa Less << | Phase 2 | Active, not recruiting | January 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less << |
NCT00794638 | Non-Hodgkin's Lymphoma ... More >> Diffuse Large B-cell Lymphoma Mantle Cell Lymphoma Follicular Lymphoma Less << | Phase 1 | Completed | - | Japan ... More >> Nagoya-city, Aichi, Japan Isehara-city, Kanagawa, Japan Kyoto-city, Kyoto, Japan Chuo-ku, Tokyo, Japan Less << |
NCT01232556 | - | Terminated(The study was termi... More >>nated prematurely on May 16, 2013, for futility. No new or unexpected safety issues were identified.) Less << | - | - | |
NCT01457144 | Mantle Cell Lymphoma | Phase 2 | Completed | - | France ... More >> Valerie ROLLAND NEYRET Grenoble, France, 38043 Less << |
NCT00825149 | Non-Hodgkin's Lymphoma | Phase 1 | Completed | - | - |
NCT01118845 | - | Completed | - | - | |
NCT01644253 | Chronic Lymphocytic Leukemia ... More >> Peripheral T-cell Lymphoma Less << | Phase 1 | Active, not recruiting | December 2019 | United States, Georgia ... More >> Augusta, Georgia, United States, 30912 United States, Ohio Columbus, Ohio, United States, 43210 United States, South Carolina Greenville Health System Greenville, South Carolina, United States, 29605 United States, Texas Houston, Texas, United States, 77030 United States, Washington Swedish Cancer Institute,1221 Madison St. Seattle, Washington, United States, 98104 Less << |
NCT01300247 | Lymphocytic Leukemia, Chronic | Phase 1 | Completed | - | United States, Alabama ... More >> Huntsville, Alabama, United States, 35805 United States, California Duarte, California, United States, 91010 La Jolla, California, United States, 92093 Los Angeles, California, United States, 90095 United States, Connecticut Southington, Connecticut, United States, 06489 United States, Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Atlanta, Georgia, United States, 30322 Marietta, Georgia, United States, 30060 United States, Illinois Chicago, Illinois, United States, 60637 United States, Maryland Boston, Maryland, United States, 02115 United States, Massachusetts Boston, Massachusetts, United States, 02114 United States, Minnesota St. Louis Park, Minnesota, United States, 55426 United States, Missouri Springfield, Missouri, United States, 65807 United States, New York Rochester, New York, United States, 14642 United States, Texas Houston, Texas, United States, 77030 United States, Washington Seattle, Washington, United States, 98109 Tacoma, Washington, United States, 98405 United States, Wisconsin Madison, Wisconsin, United States, 53705 Less << |
NCT01118845 | Non-Hodgkin's Lymphoma ... More >> Lymphoma, Large Cell Diffuse, Mantle Cell Lymphoma, Lymphoma Follicular Lymphoma Large B-Cell, Diffuse Less << | Phase 2 | Completed | - | Japan ... More >> Nagoya, Aichi, Japan Matsuyama, Ehime, Japan Kurume, Fukuoka, Japan Maebashi, Gunma, Japan Sapporo, Hokkaido, Japan Kanazawa, Ishikawa, Japan Isehara, Kanagawa, Japan Ninomaru, Kumamoto, Japan Sendai, Miyagi, Japan Kita-ku, Okayama, Japan Kurashiki, Okayama, Japan Hidaka, Saitama, Japan Izumo, Shimane, Japan Chuo-ku, Tokyo, Japan Akita, Japan Fukuoka, Japan Kagoshima, Japan Kyoto, Japan Korea, Republic of Seo-gu, Busan, Korea, Republic of Jung-gu, Daegu, Korea, Republic of Goyang-si, Gyeonggi-do, Korea, Republic of Hwasun-gun, Jeonnam, Korea, Republic of Gangnam-gu, Seoul, Korea, Republic of Seodaemun-gu, Seoul, Korea, Republic of Songpa-gu, Seoul, Korea, Republic of Less << |
NCT01292135 | B-cell Chronic Lymphocytic Leu... More >>kemia Small Lymphocytic Lymphoma Less << | Phase 1 | Completed | - | United States, Massachusetts ... More >> Dana Farber Cancer Center Boston, Massachusetts, United States, 02115 United States, New York CLL Research and Treatment Program New Hyde Park, New York, United States, 11042 Weill Medical College of Cornell University New York, New York, United States, 10065 University of Rochester Rochester, New York, United States, 14642 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Houston, Texas, United States, 77030 Less << |
NCT01300247 | - | Completed | - | - | |
NCT02414022 | - | Active, not recruiting | December 2020 | Canada, Ontario ... More >> Stronach Regional Health Centre at Southlake Newmarket, Ontario, Canada, L3Y 2P9 Less << | |
NCT01179490 | Multiple Myeloma | Phase 2 | Terminated | - | Japan ... More >> Research site Nagoya, Aichi, Japan Research site Isehara, Kanagawa, Japan Research site Fukuoka, Japan Less << |
NCT01179490 | - | Terminated | - | - | |
NCT00740415 | Lymphoma | Phase 2 | Completed | - | France ... More >> CHU de Grenoble - Hopital Michallon Grenoble, France, 38043 Less << |
NCT01678430 | Chronic Lymphocytic Leukaemia | Phase 3 | Unknown | December 2017 | United Kingdom ... More >> Countess of Chester Hospital Recruiting Chester, Cheshire, United Kingdom Principal Investigator: Salaheddin Tueger Derriford Hospital Recruiting Plymouth, Devon, United Kingdom Principal Investigator: Simon Rule Torbay Hospital Recruiting Torquay, Devon, United Kingdom Principal Investigator: Deborah Turner Royal Bournemouth Hospital Recruiting Bournemouth, Dorset, United Kingdom Principal Investigator: Helen McCarthy Dorset County Hospital Recruiting Dorchester, Dorset, United Kingdom Principal Investigator: Akeel Moosa Colchester General Hospital Recruiting Colchester, Essex, United Kingdom Principal Investigator: Mike Hamblin Basingstoke and North Hampshire Hospital Recruiting Basingstoke, Hampshire, United Kingdom Principal Investigator: Sylwia Simpson Southampton General Hospital Recruiting Southampton, Hampshire, United Kingdom Principal Investigator: Andrew Duncombe Barnet and Chase Farm Hospitals Recruiting Enfield, Hertfordshire, United Kingdom Principal Investigator: Andres Virchis Kent and Canterbury Hospital Recruiting Canterbury, Kent, United Kingdom Principal Investigator: Christopher Pocock Maidstone Hospital Recruiting Maidstone, Kent, United Kingdom Principal Investigator: Saad Rassam Princess Royal Hospital Recruiting Orpington, Kent, United Kingdom Principal Investigator: Corrine De Lord Queen Elizabeth Hospital Recruiting Woolwich, London, United Kingdom Principal Investigator: Corrine De Lord West Middlesex University Hospital Recruiting Isleworth, Middlesex, United Kingdom Principal Investigator: Magda Alobaidi Ealing Hospital Recruiting Southall, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski Hillingdon Hospital Recruiting Uxbridge, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski Belfast City Hospital Recruiting Belfast, Northern Ireland, United Kingdom Principal Investigator: Paul Kettle Royal United Hospital Recruiting Bath, Somerset, United Kingdom Principal Investigator: Christopher Knechtli Weston General Hospital Recruiting Weston-super-Mare, Somerset, United Kingdom Principal Investigator: Philip Robson Queens Hospital Recruiting Burton-upon-Trent, Staffordshire, United Kingdom Principal Investigator: Humayun Ahmad Queen Elizabeth Hospital Recruiting Gateshead, Tyne and Wear, United Kingdom Principal Investigator: Scott Marshall Queen Elizabeth Hospital Recruiting Birmingham, West Midlands, United Kingdom Principal Investigator: Paul Moss Bradford Royal Infirmary Recruiting Bradford, West Yorkshire, United Kingdom Principal Investigator: Adrian Williams Airdale General Hospital Recruiting Keighley, West Yorkshire, United Kingdom Principal Investigator: Chetan Patalappa St James University Hospital Recruiting Leeds, West Yorkshire, United Kingdom Principal Investigator: Peter Hillmen Salisbury District Hospital Recruiting Salisbury, Wiltshire, United Kingdom Principal Investigator: Jonathan Cullis Arrowe Park Hospital Recruiting Upton, Wirral, United Kingdom Principal Investigator: Ranjit Dasgupta Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Andrew Pettitt Less << |
NCT02056756 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | February 2021 | Germany ... More >> Universitätsklinikum Schleswig-Holstein (UKSH) - Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine Kiel, Germany, 24105 Italy Fo.NE.Sa. Onlus Torino, TO, Italy, 10126 Divisione di Ematologia A.O.U. Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi di Ancona Ancona, Italy, 60126 Less << |
NCT00769522 | Chronic Lymphocytic Leukemia | Phase 3 | Completed | - | Germany ... More >> Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Less << |
NCT01664910 | Lymphoma Leuk... More >>emia Less << | Phase 1 Phase 2 | Recruiting | October 2019 | United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less << |
NCT01376401 | Multiple Myeloma | Phase 2 | Completed | - | Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain Hospital Clínic Barcelona, Spain Institut català d'Oncología Barcelona, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario de la Princesa Madrid, Spain Hospital Universitario Ramón y Cajal Madrid, Spain MD Anderson Internacional Madrid, Spain Hospital General Morales Messeguer Murcia, Spain Hospital Universitario Virgen de la Victoria Málaga, Spain Hospital Universitario Central de Asturias Oviedo, Spain Hospital Universitario Virgen del Rocío Sevilla, Spain Hospital Universitario La Fe Valencia, Spain Hospital Clinico Universitario Lozano Blesa Zaragoza, Spain Less << |
NCT02424851 | Multiple Myeloma ... More >> Chronic Kidney Disease Less << | Phase 2 | Recruiting | June 2019 | United Kingdom ... More >> Basingstoke & North Hampshire Hospital Not yet recruiting Basingstoke, United Kingdom Principal Investigator: Noel Ryman Kent & Canterbury Hospital Recruiting Canterbury, United Kingdom, CT1 3NG Principal Investigator: Jindrinska Lindsay St Helier Hospital Recruiting Epsom, United Kingdom Principal Investigator: Simon Stern Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Nauman Butt Churchill Hospital Recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Karthik Ramasamy Queen Alexandra Hospital Recruiting Portsmouth, United Kingdom Contact: Helen Dignum Principal Investigator: Helen Dignum Great Western Hospital Suspended Swindon, United Kingdom Less << |
NCT02927769 | Hodgkin Disease | Phase 2 | Recruiting | March 27, 2022 | - |
NCT03524235 | Multiple Myeloma ... More >> CLL Chronic Lymphocytic Leukemia Lymphoma Less << | Phase 1 | Recruiting | May 2023 | United States, California ... More >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Hannah Coleman 310-967-4376 hannah.coleman@cshs.org Less << |
NCT03567876 | Lymphoma, Mantle-Cell | Phase 2 | Not yet recruiting | July 2025 | Italy ... More >> A.O. SS. Antonio e Biagio e Cesare Arrigo, SC Ematologia Not yet recruiting Alessandria, Italy Contact: Marco Ladetto marco.ladetto@ospedale.al.it Principal Investigator: Marco Ladetto, MD Università Politecnica delle Marche, Clinica di Ematologia Not yet recruiting Ancona, Italy Contact: Guido Gini guido.gini@ospedaliriuniti.marche.it Principal Investigator: Guido Gini, MD Centro Riferimento Oncologico, S.O.C. Oncologia Medica A Not yet recruiting Aviano, Italy Contact: Michele Spina mspina@cro.it Principal Investigator: Michele Spina, MD IRCCS Istituto Tumori Giovanni Paolo II, UOC Ematologia Not yet recruiting Bari, Italy Contact: Giacomo Loseto loseto.giacomo@gmail.com Principal Investigator: Giacomo Loseto, MD Policlinico S. Orsola-Malpighi, Istituto di Ematologia "Seragnoli" Not yet recruiting Bologna, Italy Contact: Pier Luigi Zinzani pierluigi.zinzani@unibo.it Principal Investigator: Pier Luigi Zinzani, Prof Ospedale Centrale di Bolzano, Divisione di Ematologia e T.M.O. Not yet recruiting Bolzano, Italy Contact: Michael Mian michael.mian@asbz.it Principal Investigator: Michael Mian, Prof ASST Spedali Civili, Ematologia Not yet recruiting Brescia, Italy Contact: Alessandro Re alessandro.re@asst-spedalicivili.it Principal Investigator: Alessandro Re, MD Ospedale Businco, Ematologia Not yet recruiting Cagliari, Italy Contact: Maria Giuseppina Cabras cabras.giuseppina@tiscali.it Principal Investigator: Maria Giuseppina Cabras, MD Azienda Ospedaliera di Cosenza, UOC Ematologia Not yet recruiting Cosenza, Italy Contact: Massimo Gentile massimogentile@virgilio.it Principal Investigator: Massimo Gentile, MD Azienda Ospedaliera S. Croce e Carle, SC Ematologia Not yet recruiting Cuneo, Italy Contact: Claudia Castellino castellino.c@ospedale.cuneo.it Principal Investigator: Claudia Castellino, MD Azienda Ospedaliera Universitaria Careggi, Unità funzionale di Ematologia Not yet recruiting Firenze, Italy Contact: Luigi Rigacci luigi.rigacci@unifi.it Principal Investigator: Luigi Rigacci, MD Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia, Clinica Ematologica Not yet recruiting Genova, Italy Contact: Marco Gobbi gobbi@unige.it Principal Investigator: Marco Gobbi, Prof Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia, Ematologia Not yet recruiting Genova, Italy Contact: Angela Giovanna Congiu angelagiovanna.congiu@hsanmartino.it Principal Investigator: Angela Giovanna Congiu, MD Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Ematologia Not yet recruiting Meldola, Italy Contact: Gerardo Musuraca g.musuraca@irst.emr.it Principal Investigator: Gerardo Musuraca, MD ASST Grande Ospedale Metropolitano Niguarda, SC Ematologia Not yet recruiting Milano, Italy Contact: Vittorio Ruggero Zilioli vittorioruggero.zilioli@ospedaleniguarda.it Principal Investigator: Vittorio Ruggero Zilioli, MD Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Ematologia Not yet recruiting Milano, Italy Contact: Paolo Corradini paolo.corradini@unimi.it Principal Investigator: Paolo Corradini, Prof Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia Not yet recruiting Milano, Italy Contact: Andrés Ferreri andres.ferreri@hsr.it Principal Investigator: Andrés Ferreri, MD Ospedale Maggiore Policlinico - Fondazione IRCCS Ca' Granda, Ematologia Not yet recruiting Milano, Italy Contact: Luca Baldini luca.baldini@unimi.it Principal Investigator: Luca Baldini, Prof AOU Maggiore della Carità di Novara, SCDU Ematologia Not yet recruiting Novara, Italy Contact: Luca Nassi luca.nassi@med.uniupo.it Principal Investigator: Luca Nassi, MD Azienda Ospedaliera Universitaria di Padova, Ematologia Not yet recruiting Padova, Italy Contact: Francesco Piazza francesco.piazza@unipd.it Principal Investigator: Francesco Piazza, MD A.O. Ospedali Riuniti Villa Sofia-Cervello, Divisione di Ematologia Not yet recruiting Palermo, Italy Contact: Caterina Patti k.patti@villasofia.it Principal Investigator: Caterina Patti, MD IRCCS Policlinico S. Matteo, Divisione di Ematologia Not yet recruiting Pavia, Italy Contact: Luca Arcaini luca.arcaini@unipv.it Principal Investigator: Luca Arcaini, Prof Ospedale Guglielmo Da Saliceto, UO Ematologia Not yet recruiting Piacenza, Italy Contact: Annalisa Arcari a.arcari@ausl.pc.it Principal Investigator: Annalisa Arcari, MD Ospedale delle Croci, Ematologia Not yet recruiting Ravenna, Italy Contact: Monica Tani monica.tani@auslromagna.it Principal Investigator: Monica Tani, MD Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Ematologia Not yet recruiting Reggio Calabria, Italy Contact: Caterina Stelitano caterinastelitano27@gmail.com Principal Investigator: Caterina Stelitano, MD Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova, Ematologia Not yet recruiting Reggio Emilia, Italy Contact: Francesco Merli merli.francesco@ausl.re.it Principal Investigator: Francesco Merli, MD Ospedale degli Infermi, UO Ematologia Not yet recruiting Rimini, Italy Contact: Annalia Molinari annalia.molinari@auslromagna.it Principal Investigator: Annalia Molinari, MD Policlinico Umberto I - Università "La Sapienza", Istituto Ematologia -Dipartimento di Biotecnologie Cellulari ed Ematologia Not yet recruiting Roma, Italy Contact: Maurizio Martelli martelli@bce.uniroma1.it Principal Investigator: Maurizio Martelli, Prof Università Cattolica S. Cuore, Ematologia Not yet recruiting Roma, Italy Contact: Stefan Hohaus stefan.hohaus@Unicatt.it Principal Investigator: Stefan Hohaus, MD Istituto Clinico Humanitas, UO Ematologia Not yet recruiting Rozzano, Italy Contact: Armando Santoro armando.santoro@cancercenter.humanitas.it Principal Investigator: Armando Santoro, MD Casa Sollievo della Sofferenza, UO Ematologia Not yet recruiting San Giovanni Rotondo, Italy Contact: Nicola Cascavilla n.cascavilla@operapadrepio.it Principal Investigator: Nicola Cascavilla, MD Azienda Ospedaliero Universitaria Senese, UOC Ematologia Not yet recruiting Siena, Italy Contact: Alberto Fabbri fabbri7@unisi.it Principal Investigator: Alberto Fabbri, MD A.O.U. Città della Salute e della Scienza di Torino, SC Ematologia Universitaria Not yet recruiting Torino, Italy Contact: Federica Cavallo f.cavallo@unito.it Principal Investigator: Federica Cavallo, MD A.O.U. Città della Salute e della Scienza di Torino, SC Ematologia Not yet recruiting Torino, Italy Contact: Annalisa Chiappella achiappella@cittadellasalute.to.it Principal Investigator: Annalisa Chiappella, MD Ospedale Ca' Foncello, SC Ematologia Not yet recruiting Treviso, Italy Contact: Piero Maria Stefani pmstefani@ulss.tv.it Principal Investigator: Piero Maria Stefani, MD Azienda Ospedaliera C. Panico, UOC Ematologia e Trapianto Not yet recruiting Tricase, Italy Contact: Vincenzo Pavone salentoematologia@piafondazionepanico.it Principal Investigator: Vincenzo Pavone, MD Azienda Sanitaria Universitaria Integrata di Udine, Clinica Ematologica Not yet recruiting Udine, Italy Contact: Francesco Zaja francesco.zaja@asuiud.sanita.fvg.it Principal Investigator: Francesco Zaja, Prof Ospedale di Circolo, UOC Ematologia Not yet recruiting Varese, Italy Contact: Michele Merli michelepavia@hotmail.com Principal Investigator: Michele Merli, MD Azienda Ospedaliera Universitaria Integrata di Verona, UO Ematologia Not yet recruiting Verona, Italy Contact: Fabio Benedetti fabio.benedetti@univr.it Principal Investigator: Fabio Benedetti, MD Ospedale San Bortolo, Divisione di Ematologia Not yet recruiting Vicenza, Italy Contact: Carlo Visco carlo.visco@aulss8.veneto.it Principal Investigator: Carlo Visco, MD Less << |
NCT00868413 | Chronic Lymphocytic Leukemia | Phase 1 | Completed | - | United States, California ... More >> Site Reference ID/Investigator# 17841 La Jolla, California, United States, 92093 Site Reference ID/Investigator# 25899 Stanford, California, United States, 94305-5821 United States, Maryland Site Reference ID/Investigator# 21622 Baltimore, Maryland, United States, 21231-1000 United States, Ohio Site Reference ID/Investigator# 21621 Columbus, Ohio, United States, 43210 United States, Pennsylvania Site Reference ID/Investigator# 39613 Philadelphia, Pennsylvania, United States, 19111 United States, Texas Site Reference ID/Investigator# 17943 Houston, Texas, United States, 77030-4009 Less << |
NCT03315520 | Relapsed/Refractory Malignant ... More >>Lymphomas Less << | Phase 2 | Recruiting | December 31, 2020 | Russian Federation ... More >> The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation Recruiting Moscow, Russian Federation, 105203 Contact: Vladislav Sarzhevskiy, MD, PhD +74956037217 vladsar100@gmail.com Contact: Nikita Mochkin, MD, PhD +74956037217 nickmed@yandex.ru Less << |
NCT01275209 | Follicular Lymphoma | Phase 1 | Completed | - | United States, Massachusetts ... More >> Dana Farber Cancer Institute SC-5 Boston, Massachusetts, United States, 02115 United States, Michigan Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (6) Detroit, Michigan, United States, 48201 United States, North Carolina Duke University Medical Center Duke Hem & Onc Durham, North Carolina, United States, 27710 United States, Tennessee Sarah Cannon Research Institute SC - 2 Chattanooga, Tennessee, United States, 37404 Australia, Victoria Novartis Investigative Site Prahran, Victoria, Australia, 3181 Belgium Novartis Investigative Site Gent, Belgium, 9000 Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Paris, France, 75475 Italy Novartis Investigative Site Torino, TO, Italy, 10126 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28046 Less << |
NCT01486797 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | Austria ... More >> Medical University Innsbruck, Division of Hematology and Oncology Innsbruck, Austria University Hospital Salzburg, Department of Medicine III, Center of Oncology and Hematology Salzburg, Austria Landeskrankenhaus Steyr, Department of Internal Medicine II (Hematology and Oncology) Steyr, Austria Hospital Wels-Grieskrichen, Department of Internal Medicine IV (Hematology and Oncology) Wels, Austria Belgium Cliniques universitaires Saint-Luc Brussels, Belgium Institute Jules Bordet, Department of Hematology Brussels, Belgium University Hospital Gasthuisberg, Department of Hematology Leuven, Belgium France Centre Hospitalier Universitaire Clémenceau, Department of Hematology Caen, France Hospices Civils, Department of Hematology Lyon, France Centre Hospitalier Universitaire de la Milétrie, Department of Hematology Poitiers, France Italy University Hospital, Institute of Hematology and Oncology Bologna, Italy Azienda Sanitaria Locale 8, Department of Oncology Cagliari, Italy University Hospital San Martino, Department of Hematology and Oncology Genova, Italy Niguarda Ca'Granda Hospital Milano, Italy University Scientific Research Institute San Raffaele Milano, Italy University School of Medicine, Department of Hematology Padova, Italy University La Sapienza, Department of Cellular Biotechnologies and Hematology Rome, Italy Less << |
NCT02596971 | Diffuse Large B-Cell Lymphoma,... More >> Lymphoma Follicular Less << | Phase 1 Phase 2 | Active, not recruiting | April 17, 2020 | United States, Colorado ... More >> Rocky Mountain Cancer Center - Aurora Aurora, Colorado, United States, 80012 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Florida University Miami Miami, Florida, United States, 33136 United States, New York New York Uni Medical Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Oregon Oncology Associates of Oregon, P.C.; Willamette Valley Cancer Institute Springfield, Oregon, United States, 97477 United States, Pennsylvania Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Texas Oncology Austin, Texas, United States, 78705 Texas Oncology-Tyler Irving, Texas, United States, 75063 Australia, New South Wales Concord Repatriation General Hospital; Haematology Sydney, New South Wales, Australia, 2139 Calvary Mater Newcastle Waratah, New South Wales, Australia, 2298 Australia, Queensland Royal Brisbane Hospital Brisbane, Queensland, Australia, 4029 Australia, South Australia The Queen Elizabeth Hospital; Haematology/Oncology Woodville South, South Australia, Australia, 5011 Australia, Victoria Monash Medical Centre Clayton, Victoria, Australia, 3168 Austin Hospital Heidelberg, Victoria, Australia, 3084 Italy Azienda Ospedaliera S. Orsola-Malpighi Bologna, Emilia-Romagna, Italy, 40138 Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori Meldola, Emilia-Romagna, Italy, 47014 Az. Osp. S. Maria Delle Croci; U.O. Di Ematologia Ravenna, Emilia-Romagna, Italy, 48100 Ospedale Infermi di Rimini Rimini, Emilia-Romagna, Italy, 47900 AOU Città della Salute e della Scienza di Torino - Presidio Le Molinette Torino, Lazio, Italy, 10126 Asst Papa Giovanni XXIII Bergamo, Lombardia, Italy, 24100 Azienda Ospedaliera Univ Firenze, Toscana, Italy, 50141 Less << |
NCT01292135 | - | Completed | - | - | |
NCT01465230 | - | Terminated(This study was unsu... More >>ccessful in enrolling the target number of subjects during the funding period.) Less << | - | - | |
NCT02678299 | Malignant Lymphoma | Phase 1 Phase 2 | Recruiting | - | Denmark ... More >> Department of Hematology, Aarhus University Hospital Recruiting Aarhus, Denmark, DK-8000 Contact: Francesco d'Amore, MD DMSci frandamo@rm.dk Less << |
NCT02758925 | Diffuse Large B Cell Lymphoma | Phase 2 | Unknown | December 2018 | - |
NCT01244451 | Patients With CLL Relapsing Af... More >>ter an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment Lines Less << | Phase 2 | Completed | - | Italy ... More >> Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli, Italy Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy, 70010 Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy Azienda Sanitaria di Bolzano - Ospedale Centrale - Ematologia e Centro TMO Bolzano, Italy Azienda ASL di Cagliari Cagliari, Italy, 9121 U.O.C. di Onco-Ematologia - Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche Campobasso, Italy Ospedale Ferrarotto Catania, Italy, 95124 Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 U.O. Ematologia - P.O. Annunziata - A.O. di Cosenza Cosenza, Italy Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Policlinico di Careggi, Università delgi studi di Firenze Firenze, Italy Clinica Ematologica - Università degli Studi Genova, Italy ASL Le1 P.O. Vito Fazzi - U.O. di Ematologia Lecce, Italy, 73100 Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Messina, Italy Messina Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milano, Italy Unità Trapianto di Midollo Ist. Nazionale Tumori Milano, Italy Sez. di medicina Interna Oncologia ed Ematologia Modena, Italy Ospedale San Gennaro - ASL Napoli 1 Napoli, Italy, 80143 U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Dipartimento Emato-Oncologia A.O. "Bianchi-Melacrino-Morelli" Reggio Calabria, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy Università degli studi di Roma La Cattolica Roma, Italy Ospedale S.Eugenio Rome, Italy, 00144 Ospedale Casa Sollievo della sofferenza San Giovanni Rotondo, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni Terni, Italy Div. di Ematologia "Molinette" Osp. Maggiore S. G. Battista Torino, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Policlinico G.B. Rossi Verona, Italy, 37134 Less << |
NCT02162888 | Cancer Which Has Either Progre... More >>ssed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate Less << | Phase 1 | Completed | - | United States, California ... More >> Oncology Institute of Hope and Innovation Long Beach, California, United States United States, Kansas Cancer Center of Kansas Wichita, Kansas, United States United States, New Jersey Regional Cancer Care Associates Cherry Hill, New Jersey, United States United States, Pennsylvania Penn State University Hershey Medical Center Hershey, Pennsylvania, United States United States, South Carolina Greenville Hospital System University Medical Center Greenville, South Carolina, United States United States, Texas Texas Oncology Fort Worth, Texas, United States Scott & White Healthcare Temple, Texas, United States United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States United States, Washington Evergreen Hematology & Oncology Spokane, Washington, United States Yakima Valley Memorial Hospital/North Star Lodge Yakima, Washington, United States Less << |
NCT02434484 | - | Recruiting | June 2020 | Korea, Republic of ... More >> Eisai Trial Site #7 Not yet recruiting Busan, Korea, Republic of Eisai Trial Site #8 Not yet recruiting Busan, Korea, Republic of Eisai Trial Site #6 Not yet recruiting Daegu, Korea, Republic of Eisai Trial Site #4 Recruiting Daejeon, Korea, Republic of Eisai Trial Site #5 Not yet recruiting Daejeon, Korea, Republic of Eisai Trial Site #9 Not yet recruiting Incheon, Korea, Republic of Eisai Trial Site #1 Not yet recruiting Seoul, Korea, Republic of Eisai Trial Site #2 Not yet recruiting Seoul, Korea, Republic of Eisai Trial Site #3 Not yet recruiting Seoul, Korea, Republic of Less << | |
NCT01974440 | Lymphoma | Phase 3 | Active, not recruiting | August 3, 2021 | - |
NCT02717624 | Mantle Cell Lymphoma (MCL) | Phase 1 | Active, not recruiting | May 2026 | United States, Kentucky ... More >> Louisville, Kentucky, United States United States, Michigan Ann Arbor, Michigan, United States United States, New Jersey Hackensack, New Jersey, United States Morristown, New Jersey, United States United States, New York Lake Success, New York, United States United States, Ohio Columbus, Ohio, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Houston, Texas, United States United States, Washington Seattle, Washington, United States Italy Bologna, Italy Poland Krakow, Poland Olsztyn, Poland Warsaw, Poland Łódź, Poland Less << |
NCT01465230 | Chronic Lymphocytic Leukemia | Phase 2 | Terminated(This study was unsu... More >>ccessful in enrolling the target number of subjects during the funding period.) Less << | - | United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06519 Less << |
NCT02836639 | Lymphoma, Non-Hodgkin | Phase 2 | Recruiting | - | Korea, Republic of ... More >> Pusan National University Hospital Recruiting Busan, Korea, Republic of Contact: Hojin Shin hojinja@hanmail.net Less << |
NCT01056510 | Lymphocytic Leukemia, Chronic | Phase 4 | Completed | - | - |
NCT01056510 | - | Completed | - | - | |
NCT01133158 | - | Completed | - | - | |
NCT02954406 | Lymphoma, Non-Hodgkin | Phase 1 | Recruiting | April 26, 2019 | United States, Arizona ... More >> University of Arizona Cancer Center, Tucson Recruiting Tucson, Arizona, United States, 85724 United States, California University of California San Diego (UCSD) - Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Cedars-Sinai Medical Center (CSMC) - Samuel Oschin Comprehensive Cancer Institute Not yet recruiting West Hollywood, California, United States, 90048 United States, Kentucky University of Louisville Kentucky James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 United States, Maryland Center for Cancer and Blood Disorders Recruiting Bethesda, Maryland, United States, 20817 United States, Massachusetts Tufts Medical Center Not yet recruiting Boston, Massachusetts, United States, 02111 United States, Michigan Henry Ford Hospital Recruiting Detroit, Michigan, United States, 48202-2608 United States, New York NYU Langone Medical Center - NYU Medical Oncology Associates Recruiting New York, New York, United States, 10016-4744 United States, North Carolina University of North Carolina - Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27514 United States, Ohio University Hospitals of Cleveland Recruiting Cleveland, Ohio, United States, 44106 United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Quebec McGill University - Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Less << |
NCT01133158 | Non-Hodgkin's Lymphoma | Phase 2 | Completed | - | Spain ... More >> Complejo Hospitalario Universitario de Santiago Santiago, A Coruña, Spain, 15706 Hospital Txagorritxu Vitoria, Alava, Spain, 01009 Hospital San Juan de Alicante San Juan de Alicante, Alicante, Spain, 03550 Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital de Galdakao Galdakao, Bilbao, Spain, 48960 Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11407 Hospital Fundación de Alcorcón Alcorcón, Madrid, Spain, 289222 Hospital de Getafe Getafe, Madrid, Spain, 28901 Hospital Severo Ochoa Leganés, Madrid, Spain, 28911 Hospital Puerta de Hierro Majadahonda, Madrid, Spain, 28222 Hospital Son Llàtzer Palma de Mallorca, Mallorca, Spain, 07010 Hospital Son Espases Palma de Mallorca, Mallorca, Spain, 07014 Hospital Universitario Virgen de Arrixaca El Palmar, Murcia, Spain, 30120 Clínica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Hospital Universitario de Canarias La Laguna, Tenerife, Spain, 38320 Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Hospital del Mar Barcelona, Spain, 08003 Hospital Vall d´Hebron Barcelona, Spain, 08035 Hospital Clinic i Provincial Barcelona, Spain, 08036 Hospital de Basurto Bilbao, Spain, 48013 Hospital San Pedro Alcántara Cáceres, Spain, 10002 Hospital Puerta del Mar Cádiz, Spain, 11009 Hospital de Jaén Jaén, Spain, 23007 Hospital Gregorio Marañón Madrid, Spain, 28009 Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital La Paz Madrid, Spain, 28046 Hospital Morales Meseguer Murcia, Spain, 30008 Complejo Hospitalario Carlos Haya Málaga, Spain, 29010 Hospital de Salamanca Salamanca, Spain, 37007 Hospital General de Segovia Segovia, Spain, 42002 Hospital Virgen del Rocío Sevilla, Spain, 41013 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Hospital General de Valencia Valencia, Spain, 46014 Hospital Arnau de Vilanova Valencia, Spain, 46015 Hospital Universitario Dr. Peset Valencia, Spain, 46017 Hospital Río Hortega Valladolid, Spain, 47012 Hospital Virgen de la Concha Zamora, Spain, 49022 Hospital Clínico de Zaragoza Zaragoza, Spain, 50009 Hospital Miguel Servet Zaragoza, Spain, 50009 Less << |
NCT00856830 | Small Cell Lung Cancer ... More >> Extensive Stage Lung Cancer Chemonaive Less << | Phase 1 Phase 2 | Completed | - | United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 - 0104 United States, Georgia Georgia Cancer Specialists Marietta, Georgia, United States, 30060 Less << |
NCT01671904 | Chronic Lymphocytic Leukemia | Phase 1 | Active, not recruiting | June 25, 2020 | United States, California ... More >> University of California San Diego Medical Center La Jolla, California, United States, 92093-5354 United States, Illinois Ingalls Hospital; Cancer Clinical Trials Harvey, Illinois, United States, 60426 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Washington Evergreen Hematology and Oncology Spokane, Washington, United States, 99218 North Star Lodge Yakima, Washington, United States, 98902 Yakima Valley Memorial Hospital/North Star Lodge Yakima, Washington, United States, 98902 France Hopital Claude Huriez Lille, France, 59037 Hopital Saint Eloi Montpellier, France, 34295 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Centre Henri Becquerel Rouen, France, 76038 Germany Apotheke des Universitätsklinikums Freiburg Freiburg, Germany, 79106 UKSH Klinik für Innere Medizin II, Hämatologie und Internistische Onkologie Kiel, Germany, 24105 Universitatsklinik Koln Köln, Germany, 50924 Klinikum Schwabing München, Germany, 80804 Universtitätsklinikum Ulm; Klinik für Innere Medizin III Ulm, Germany, 89081 Less << |
NCT00856830 | - | Completed | - | - | |
NCT00612183 | Non-Hodgkin's Lymphoma ... More >> Mantle Cell Lymphoma Less << | Phase 2 | Completed | - | Japan ... More >> Nagoya, Aichi, Japan Kashiwa, Chiba, Japan Sapporo, Hokkaido, Japan Isehara, Kanagawa, Japan Sendai, Miyagi, Japan Moriguchi, Osaka, Japan Hamamatsu, Shizuoka, Japan Utsunomiya, Tochigi, Japan Chuo, Tokyo, Japan Koto, Tokyo, Japan Shibuya, Tokyo, Japan Shinagawa, Tokyo, Japan Fukuoka, Japan Kagoshima, Japan Kumamoto, Japan Kyoto, Japan Nagoya, Japan Less << |
NCT02257567 | Lymphoma | Phase 1 Phase 2 | Recruiting | July 12, 2021 | - |
NCT01523860 | Follicular Lymphoma | Phase 2 | Completed | - | Italy ... More >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) Meldola, Forlì-Cesena, Italy, 47014 Ematologia e Trapianto Ospedale Card.Panico Tricase, Lecce, Italy Ematologia, A.O. San Gerardo Monza, Milano, Italy, 20052 Oncologia Medica ed Ematologia, Istituto Clinica Humanitas Rozzano, Milano, Italy, 20089 Divisione di Oncologia Medica A, Centro di Riferimento Oncologico Aviano, Pordenone, Italy, 33081 UO Oncologia ed Onco-Ematologia, Ospedale di Rimini Rimini, Rn, Italy Divisione di Ematologia Ospedale SS. Antonio e Biagio Alessandria, Italy, 15100 SOS Ematologia Ospedale C. Massaia Asti, Italy, 14100 Ematologia con Trapianto, Università di Bari Bari, Italy, 70124 Medicina Interna, Ospedale degli Infermi Biella, Italy, 13800 Istituto di Ematologia ed Oncologia Medica A. Seragnoli Policlinico S. Orsola Bologna, Italy, 40138 Divisione di Ematologia e TMO, Ospedale di Bolzano Bolzano, Italy, 39100 S.C. di Ematologia, Spedali Civili Brescia, Italy, 25123 Divisione di Ematologia, Ospedale Businco Cagliari, Italy, 09121 Divisione di Ematologia, Ospedale di Catania Catania, Italy Azienda Ospedaliera Santa Croce e Carle Cuneo, Italy, 12100 Clinica Ematologica Policlinico Carreggi Firenze, Italy, 50134 Divisione di Ematologia, Policlinico Careggi Firenze, Italy Ematologia I, A.O.U. San Martino Genova, Italy, 16132 S.C. Medicina Trasfusionale ed Ematologia , P.O. Ivrea Ivrea, Italy, 10015 S.C. Ematologia, Azienda Ospedaliera Papardo Messina, Italy, 98158 Divisione di Ematologia, Ospedale Niguarda Milano, Italy, 20162 Ematologia e Trapianto IRCCS, Istituto Nazionale dei Tumori Milano, Italy Policlinico La Marcora Milano, Italy UO Ematologia, II Facoltà di Medicina e Chirurgia Università Federico II Napoli, Italy, 80131 SCDU Ematologia, AOU Maggiore della Carità Novara, Italy, 28100 UO Ematologia, Università - Policlinico San Matteo Pavia, Italy, 27100 Ematologia Ospedale Santa Maria delle Croci Ravenna, Italy, 48100 Div. Ematologia A.O. "Bianchi Melacrino Morelli" Reggio Calabria, Italy, 89100 Università Cattolica del Sacro Cuore Roma, Italy, 00168 Dipartimento di biotecnologie cellulari ed ematologia Ospedale Umberto I, Università La Sapienza Roma, Italy Ospedale Santa Maria di Terni Terni, Italy, 05100 Osp. San Giovanni Battista - Biologia Molecolare Torino, Italy, 10126 Osp. San Giovanni Battista - Ematologia 2 Torino, Italy, 10126 Ospedale S. Chiara Trento, Italy Ematologia Ospedale Santa Maria Di Ca' Foncello Treviso, Italy, 31100 Clinica di Ematologia, A.O.U. di Udine Udine, Italy, 33100 Less << |
NCT01423539 | Diffuse Large B-Cell Lymphoma | Phase 2 | Withdrawn(The NAVIGATE study h... More >>as been terminated due to non-safety related reasons.) Less << | February 2014 | United States, California ... More >> Fountain Valley, California, United States, 92708 United States, Florida Hudson, Florida, United States, 34667 United States, Georgia Lawrenceville, Georgia, United States, 30045 United States, Illinois Centralia, Illinois, United States, 62801 Harvey, Illinois, United States, 60426 United States, Indiana Terre Haute, Indiana, United States, 47802 United States, Kentucky Hazard, Kentucky, United States, 41701 Paducah, Kentucky, United States, 42003 United States, Maryland Rockville, Maryland, United States, 20850 United States, Missouri Jefferson City, Missouri, United States, 65109 United States, Montana Great Falls, Montana, United States, 59405 United States, Ohio Newark, Ohio, United States, 43055 United States, Tennessee Nashville, Tennessee, United States, 37203 Less << |
NCT01466153 | Chronic Lymphocytic Leukemia (... More >>CLL) Less << | Phase 2 | Completed | - | - |
NCT01776840 | Mantle Cell Lymphoma | Phase 3 | Active, not recruiting | October 12, 2021 | - |
NCT01832597 | - | Completed | - | Italy ... More >> UO di Ematologia, S.O. Annunziata Cosenza, CZ, Italy, 87100 Dipartimento di Oncologia, Ematologia e Patologie dell'Apparato Respiratorio, Universita` di Modena e Reggio Emilia Modena, MO, Italy, 41124 UO di Ematologia, AOUP Paolo Giaccone, Palermo, PA, Italy, 90127 Less << | |
NCT02148913 | Multiple Myeloma | Phase 1 | Active, not recruiting | December 2018 | United States, Michigan ... More >> Spectrum Health Grand Rapids, Michigan, United States, 49503 Less << |
NCT01332617 | Myeloma | Phase 2 | Withdrawn(Investigators no lon... More >>ger interested in activating study) Less << | February 2019 | - |
NCT01466153 | - | Completed | - | - | |
NCT01612988 | B-cell Chronic Lymphocytic Leu... More >>kemia (B-CLL) Less << | Phase 2 | Terminated(Other drugs others ... More >>studies) Less << | - | France ... More >> Tournilhac Clermont Ferrand, France, 63000 Less << |
NCT00168922 | Recurrent Small Cell Lung Canc... More >>er Less << | Phase 2 | Unknown | - | Germany ... More >> Hematology & Oncology Charité CBF Berlin, Germany Recruiting Berlin, Germany, 12203 Contact: Ulrich Keilholz, MD +49-30-8445-3596 ulrich.keilholz@charite.de Contact: Alexander Schmittel, MD +49-30-8445-3090 alexander.schmittel@charite.de Less << |
NCT00069758 | Non-Hodgkin's Lymphoma | PHASE2 | COMPLETED | 2025-04-07 | University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294-3300, United States|Comprehensive Cancer Center-Desert Regional Medical Center, Palm Springs, California, 92262, United States|San Diego Cancer Center, Vista, California, 92083, United States|Georgetown University Medical Center - Lombardi Cancer Center, Washington, District of Columbia, 20007, United States|Mountain States Tumor Institute, Boise, Idaho, 83712, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|The Cancer Institute of New Jersey, New Brunswick, New Jersey, 08901, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|The Sarah Cannon Cancer Center, Nashville, Tennessee, 37203, United States|Southwest Regional Cancer Center, Austin, Texas, 78705, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Virginia Medical Center, Charlottesville, Virginia, 22908, United States|Queen Elizabeth Health Sciences Centre, Halifax, Nova Scotia, B3H 2Y9, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, K1H 8L6, Canada|Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, M4N 3M5, Canada|CHA Hopital Enfant-Jesus, Quebec, G1J 1Z4, Canada Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() | 1mg | 5mg | 10mg |
1 mM 5 mM 10 mM | 2.53mL 0.51mL 0.25mL | 12.67mL 2.53mL 1.27mL | 25.33mL 5.07mL 2.53mL | |
Dissolving Methods | Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|